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It remains unclear whether lapses in ambulatory care for diabetic patients 
influences the subsequence medical utilization. Therefore, the objective of this study was 
to clarify whether different duration of ambulatory care lapses were associated with the 
stroke utilization in diabetic patients. 
We conducted a retrospective cohort study by using Taiwan National Health 
Insurance Research Database. Study population were diabetic patients aged 20 and over 
with subsequence ischemic stroke. According to lapses between the last diabetic 
ambulatory care and the ischemic stroke, patients were classified into five groups(from 
group A to group E), which were lapse A) within 90 days, B) within 91 to 180 days, C) 
within 181 to 270 days, D) within 271 to 365 days, and E) over 365 days. The interests 
outcomes were stroke hospitalization expenditure, length of stay, and severity. Groups 
were compared on characteristics at the ischemic stroke, the use of diabetic care and 
stroke utilization by using analysis of variance test for continuous variables and 
chi-square test for categorical variables, as appropriate. The multivariate regression 
models and multinomial logistic regression model was used to estimate the association 
between different duration of ambulatory care lapses and interested outcomes. 
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A total of 76,194 diabetic patients with subsequence ischemic stroke during 2002 
to 2012 were included for analysis. Average hospitalization cost per day was 1.03% 
higher for patients in group E when compared to patients in group A. Patients in group B, 
group D, and group E, comparing to group A, had statistically significant longer length of 
stay for stroke, which were 0.79, 1.05 and 0.65 days, respectively. Stroke severity was 
higher associated with diabetic patients in group B, group D, and group E when 
compared to patients in group A. 
In conclusion, this study found that diabetic patients with subsequence ischemic 
stroke having the last ambulatory care over 365 days tend to have higher severity, higher 
hospitalization cost per day, and longer length of stay for ischemic stroke. Therefore, this 
study suggests to enhance better monitoring and better management for all diabetic 
patients especially for those patients with longer lapses.  
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Chapter 1: Introduction 
Statement of the Problem 
Primary care plays an important role in the health care system all over the world. 
It is not only the first contact but also continuous care for patients. Patients with chronic 
conditions, such as diabetes mellitus, is highly recommended to manage their disease 
with regular appointments in ambulatory care setting for continuous care. Although 
studies for continuous care have been studied a lot in past decades, little is focused on 
discontinuous care. Therefore, this study tries to understand the pattern of ambulatory 
care. 
Diabetes mellitus is a global health care issue and an important public health 
challenge because of its complexity and requiring continuous medical care with glycemic 
control. Patients with diabetes mellitus are recommended to have frequent diabetic visits 
for medications or screenings in order to prevent the complications. Diabetes mellitus has 
also been listed one of ambulatory care sensitive conditions which indicates appropriate 
ambulatory care can prevent or reduce the need for hospital admission. Therefore, it is 
important to understand the lapses of ambulatory care among diabetic patients. 
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Cardiovascular disease, including stroke, is the leading cause of illness and death in 
people with diabetes mellitus. It knows that people with diabetes mellitus have an 
increased risk of developing ischemic stroke. Stroke may cause physical disability, 
burdens to self, family and society, decreased national productivity and economic losses. 
Although mortality from stroke is dropping, the number of people having strokes is rising 
each year due to the aging of population and other signs that strokes have increased in 
younger groups. Previous studies had indicated the relationship between diabetic mellitus 
and risk of stroke. However, little is known the role of specific ambulatory care prior to 
ischemic stroke. It is also unknown how ambulatory care lapses influences stroke medical 
utilization for diabetic patients.  
Since Taiwan conducted a National Health Insurance Program for twenty years 
with standard formats documented, patients’ medical treatment profile on admission, 
ambulatory care and prescription can be easily retrieved for analysis. Therefore, this study 
expects to examine the relationship between the duration of ambulatory care lapses and 
stroke medical utilization in diabetic patients with subsequence ischemic stroke through 
Taiwan National Health Insurance Database. The results will provide a reference for policy 
maker and clinic professionals in improving diabetes care and management.  
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Research Objective and Study Aims 
The purpose of this study is to understand whether ambulatory care lapses influence 
stroke medical consumption among diabetic patients. Diabetic patients with appropriate 
ambulatory care and regular physicians visit for diabetes management can prevent or 
reduce the need for hospital admission and result in reduced medical utilization. 
Therefore, the research objective is to test the hypothesis that diabetic patients with shorter 
ambulatory care lapses prior to stroke are related with reduced stroke consumptions. The 
specific study aims are list below.  
Aim1: To understand the baseline characteristics for different pattern of ambulatory 
care in diabetic patients  
Aim2: To understand the utilization of ambulatory care among diabetic patients 
prior to stroke hospitalization 
Aim3: To understand whether ambulatory care lapses in diabetic patients prior to 





Chapter 2: Literature Review 
Diabetes mellitus has become a global health care issue and an important public 
health challenge. Several studies have indicated that patients with diabetes mellitus have a 
high risk of microvascular and macrovascular which influence the whole body. The reason 
is that diabetes mellitus will make the renal artery and systemic arteriosclerosis, and result 
in peripheral vascular resistance and systolic blood pressure rise. High blood pressure will 
accelerate the vascular disease in diabetic patients, and cause complications in the brain, 
eyes, heart, kidney and other organs. Many studies had indicated that diabetic patients with 
more complications will incur the higher medical consumption.1-3 Diabetes mellitus is a 
well-established risk factor for future ischemic stroke. Among patients with cardiovascular 
disease, 30% of them had type 2 diabetes mellitus.4 It was known that diabetic patients with 
proper diabetes care and good glycemic control can reduce cardiovascular disease and 
medical consumptions.5-9 However, study of ambulatory care lapses in diabetic patient is 
lacking from previous studies.  
In order to improve the quality and cost-effectiveness of care, private and public 
policy makers and health insurance plans in many countries have executed disease 
management to help treat chronic illnesses, such as diabetes mellitus and stroke. The 
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overall perceived health status of diabetic patients is a significant predictor of 
complication risk and an important indicator for diabetes care management. Therefore, it 
is vital to have face-to-face encounters with care managers and health educators in 
communicating about patients’ health status and self-care. Therefore, this study expects to 
examine the relationship between lapses in ambulatory care and medical consumptions 
through national insurance administrative data in order to provide a reference for policy 
maker and clinic professionals in patient care. To better understand the issue of diabetic 
care lapses prior to stroke hospitalization in diabetic population, a literature review that 
have been published and related on this topic was conducted below. 
Diabetes mellitus 
Numbers of diabetes population is growing throughout the world. The rise of 
diabetes mellitus is associated with economic development, ageing populations, 
increasing urbanization, dietary changes, reduced physical activity, and changes in other 
lifestyle patterns.10 The International Diabetes Federation (IDF) indicates that 8.3% of 
adults, 382 million people, have diabetes in 2013,11 and the number of adults with disease 
worldwide in 2015 rises to 415 million, and estimates to have 642 million people living 
with diabetes by 2040.12 According to a report from the American Heart Association, an 
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estimated 23.4 million adults have diagnosed diabetes mellitus based on data from 2011 
to 2014 in the United States. The prevalence of diabetes mellitus increased from 8.4% 
(between 1988 and 1994) to 12.1% (between 2005 and 2010). This increase was most 
pronounced among those ≥ 65 years of age, especially for the oldest age group.13 It is 
estimated that one of 10 adults is affected by diabetes.14 According to Taiwan Health 
Promotion Administration, the prevalence of diabetes mellitus in adults aged 18 and older 
is 12.4% (male 14.4%, female 10.3%), and it is about 1.5 million (6.5%) Taiwanese 
suffered from this disease.15  
Diabetes may be diagnosed based on plasma glucose criteria, either the fasting 
plasma glucose (FPG≥126 mg/dL) or the 2-h plasma glucose (2-h PG≥200 mg/dL) value 
after a 75-g oral glucose tolerance test (OGTT) or hemoglobin A1c criteria (HbA1c 
≥6.5%).16 Diabetes can be classified into four general categories: (1) Type 1 diabetes, 
accounts for 5–10% of diabetes, which is due to autoimmune β-cell destruction, usually 
leading to absolute insulin deficiency; (2) Type 2 diabetes, accounts for 90–95% of all 
diabetes, which is due to a progressive loss of β-cell insulin secretion, frequently on the 
background of insulin resistance; (3) Gestational diabetes mellitus which is diabetes 
diagnosed in the second or third trimester of pregnancy, but was not clearly overt diabetes 
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prior to gestation; (4) Specific types of diabetes due to other causes, e.g., monogenic 
diabetes syndromes, diseases of the exocrine pancreas, and drug- or chemical-induced 
diabetes.16 Type 1 diabetes and type 2 diabetes are heterogeneous diseases in which 
clinical presentation and disease progression may vary considerably. Although 
pharmacologic therapy for type 1 diabetes and type 2 diabetes are different, there is no 
different for glycemic targets and diabetic ambulatory care based on the American 
Diabetes Association (ADA) guideline.16 
Patients with diabetes mellitus have a high risk of microvascular, including 
retinopathy, nephropathy, and neuropathy, and macrovascular, including coronary heart 
disease, cerebrovascular disease, and peripheral arterial disease, complications. The 
distinct macrovascular complications of diabetes are related to the pathogenesis of stroke, 
a cerebrovascular disease. Therefore, diabetes is a well-established risk factor for future 
ischemic stroke. 
The relationship between stroke and diabetes mellitus 
All of the data shown that population is aging worldwide17, and stroke has become a 
common health problems among older people. Stroke, also known as cerebrovascular 
accident, is the fifth cause of death and the leading cause of adult disability in the United 
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States. It is estimated that 795,000 people experience a stroke each year, and 77% of these 
people are the first event while remain of 23% are recurrent stroke events.14 In 2011, one of 
20 deaths in the United States is caused by stroke.14 Over the past decades with a striving 
for stroke management, stroke mortality has gradually fallen due to the improvement of 
stroke survival, reduction of stroke incidence and lower fatality rates.14  
Depending on the conditions of the blood vessel, strokes can be divided into two 
categories clinically. Ischemic strokes account for 75% of strokes while hemorrhagic 
strokes account for the remaining 25%. Factors for strokes can be divided into two 
categories: risk factors that cannot be changed, such as age and sex, and risk factors that 
can be modified, including hypertension, diabetes, and hyperlipidemia.14,17 Many studies 
have also indicated that strokes are closely correlated to hypertension, diabetes, and heart 
disease.18,19 According to research form Taiwan stroke registry, about 80% of stroke 
patients have medical history in hypertension and 40 to 50% of stroke patients have 
diabetes mellitus and hyperlipidemia.20  
Diabetes mellitus is a major cause of stroke, and the seventh leading cause of death 
in adults in the United States.21 People with diabetes mellitus have an increased risk of 
developing stroke by approximately 3% each year.10,22,23 Also, self-reported history of 
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diabetes mellitus was associated with an increased risk of all stroke and ischemic 
stroke.24 Previous diabetes was also associated with post-stroke mortality.25 The overall 
relative risk of stroke is 1.5 to 6 times greater in patients with diabetes mellitus, while the 
relative risk for stroke is 10 times higher in diabetic patients younger than 55 years old.26-28 
Recurrent stroke is also twice more frequent in diabetic patients.28 In addition, diabetic 
patients who survive a stroke are more likely to be debilitated subsequently and have 
poorer functional outcomes than non-diabetics. 29-32 
Inadequate glycemic control is a risk factor for poor outcome and increased 
mortality.28 In Chinese adults, diabetes mellitus is associated with a substantially increased 
risk of death, especially from cardiovascular disease, almost half of which is due to 
stroke.33 Cardiovascular diseases, including stroke, accounted for about 65% of 
diabetes-related mortality,34,35 is the leading cause of illness and death in patients with type 
2 diabetes.36 
Patients with diabetes mellitus are more prone to ischemic rather than 
hemorrhagic stroke. Following are some reasons. First, long-term hyperglycemic can 
cause endothelial dysfunction and increased small-vessel resistance, which lead to 
atherosclerosis and ischemic stroke. Second, diabetic patients are easily to have polyuria, 
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which lead to water deficient and increased blood viscosity. Inadequate autoregulation of 
blood flow renders the brain vessels more vulnerable to damage and, eventually, 
occlusion. Third, cardiac autonomic neuropathy, is a complication of diabetes, may 
contribute to the pathogenesis of diabetic nephropathy as well as to the pathogenesis of 
stroke; Fourth, diabetes easily causes heart disease and leads to cardiogenic brain 
infarction.28,37-40 It is known that an appropriate management for diabetes care can reduce 
the incidence of stroke and complications in diabetic patients.41 
Diabetes care 
A previous report pointed that 20.8% of adults with diabetes mellitus had their 
disease treated and controlled, 46.4% had their diabetes, 9.9% were aware they had 
diabetes but were not treated, and the rest were undiagnosed.13 Poor diabetes 
managements could lead to serious complications, poorer clinical outcomes and early 
death.33 Diabetes care got more attention from St. Vincent Declaration in 1989, which 
pointed out the importance of reduced complications from diabetes as well as controlling 
glycemic, hyperlipidemia and blood pressure. In 1999, the United States conducted 
Diabetes Quality Improvement Program in improving diabetes care through accountability 
measures, such as percentage of patients having at least once HbA1c test in a year. In 2000, 
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eye examinations, HbA1c testing, and lipid testing have been required to collect and report 
in all 50 states.42 The ADA guidelines also suggest to measure and control 
glycohemoglobin, cholesterol and microalbuminuria for patients with diabetes.32 
Fallowing are main points for diabetes care. 
Blood pressure control 
Hypertension is a common comorbidity that affects the majority of diabetic patients, 
and a major risk factor for both cardiovascular disease and microvascular complications. 
Hypertension is often the result of underlying diabetic kidney disease in patients with 
type 1 diabetes, and it usually coexists with other cardiometabolic risk factors for patients 
with type 2 diabetes. Individuals with diabetes should be treated to a systolic blood 
pressure goal of <140 mmHg and a diastolic blood pressure goal of <90 mmHg. According 
to American Diabetes Association, diabetic patients with high risk of cardiovascular 
disease was suggested to control systolic blood pressure at <130mmHg and diastolic blood 
pressure <80mmHg. Besides, blood pressure should be measured at every routine visit.16  
Glycemic control 
To monitor and control glycemic is fundamental to diabetes management.43 It is 
known that glycemic control is an important predictor for many complications of diabetes, 
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and its improvement has been found to lead to cost savings.44 Therefore, HbA1C testing 
should be performed routinely in all patients with diabetes. Because HbA1C reflects 
average glycaemia over approximately three months, the ADA guideline recommends to 
measure HbA1c approximately every three months in order to determine whether patients’ 
glycemic targets have been reached and maintained.16 For those patients have stable 
glycemic control, it is suggested to perform the HbA1c test at least two times a year, and 
lower HbA1c to approximately 7%.45 The international guidelines also suggest 
comprehensive management of patients with DM in order to maintain glycemic control, 
often measured by HbA1c, and reduce the risk of diabetes-related complications.32,43  
Cholesterol Control 
Patients with type 2 diabetes have an increased prevalence of lipid abnormalities. 
Dyslipidemia can lead to atherosclerotic cardiovascular disease, which including acute 
coronary syndromes, myocardial infarction, stable or unstable angina, coronary or other 
arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease.16 
Control of diabetes and high cholesterol appear to have contributed to the decline in 
stroke mortality.14 The American Diabetes Association suggested that appropriate target 
goal for low-density lipoprotein cholesterol among diabetic patients is <100mg/dl.16 In 
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adult patients with diabetes, it is recommended to have a screening lipid profile (total 
cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and 
triglycerides) at the time of diabetes diagnosis, at an initial medical evaluation, and/or at 
age 40 and periodically (e.g., every 1 year) thereafter.45,46  
Conduct Eye exam 
Diabetic retinopathy is a highly specific vascular complication of diabetes, with 
prevalence strongly related to the duration of diabetes.46 Hyperglycemic increases the risk 
of eye problems. The actual risk of getting microvascular complications, like 
microalbuminuria and retinopathy progression, starts at HbA1c level of 7%.31 Therefore, a 
dilated eye exam can tell whether you have diabetes retina problems. It is known that 
having a dilated eye exam at least once a year can prevent most instances of severe vision 
loss or blindness from diabetes. 
Exam Microalbuminuria 
Diabetic nephropathy occurs in 20–40% of patients with diabetes and is the single 
leading cause of end stage renal disease.46 Albuminuria was a significant predictor for the 
evaluated renal endpoints. Persistent albuminuria in the range of 30–299 mg/24h has been 
shown to be an early stage of diabetic nephropathy in type I diabetes and a marker for 
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development of nephropathy in type 2 diabetes. The first clinical manifestation of diabetic 
kidney disease is usually the development of microalbuminuria.47 
Intervention Program 
Among individuals at high risk for developing type 2 diabetes, structured programs 
that emphasize lifestyle changes with dietary strategies can reduce the risk for developing 
diabetes. Patients with diabetes and high-risk conditions should be educated regarding 
their risk factors and appropriate management.46 Taiwan have executed the Diabetes 
Shared Care Program(DSCP) in 2001 in order to increase the quality of diabetes care. 
DSCP is a diabetes care model involving multidisciplinary approach and qualified diabetes 
caregivers, including physician, diabetes educator, and dietitian, in order to provide 
continuity of care, and to reduce the occurrence of diabetes complications for diabetes 
patients. By 2013, about 1.18 million of diabetic patients have ever participated in DSCP in 
Taiwan.48 It is known that participants in the DSCP was associated with lower risks of 
cardiovascular events, stroke, and all-cause mortality.49 In order to achieve diabetes 
optimal control goals, a long-term control of diabetes by comprehensive education 
program and regular screening of diabetes-related complications are needed. 
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The Role of Community Health Workers 
According to American Public Health Association, community health workers 
(CHWs) are frontline public health workers who are trusted members of and/or have an 
unusually close understanding of the community served. This trusting relationship 
enables CHWs to serve as a liaison, link, or intermediary between health/social services 
and the community to facilitate access to services and improve the quality and cultural 
competence of service delivery.50 Therefore, CHW typically work in their own 
communities, share cultural, economic, linguistic and other characteristics with the 
patients they work with, and are able to build close, trusting relationships with 
communities because of a deep knowledge of that community.50 The five main roles of 
CHWs includes patient care, education, support for care delivery provided by other health 
professionals, care coordination, and social support.51 CHWs, who are vital links between 
health services and the community, serve in a variety of capacities, typically focusing on 
strategies to improve self-management.52  
Self-management for diabetic patients is an evolutionary process of development of 
knowledge or awareness in order to manage diabetes and prevent or delay the 
complications.53 Because the majority of day-to-day care in diabetes is handled by 
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patients and/or families54, it is important to have a self-management of diabetes for 
diabetic patients. It was known that seven essential self-care behaviors in people with 
diabetes can predict good outcomes namely healthy eating, being physically active, 
monitoring of blood sugar, compliant with medications, good problem-solving skills, 
healthy coping skills and risk-reduction behaviors.55 However, numerous barriers may 
influence diabetes control, such as failure to adhere to treatment, lack of support for 
self-management, lack of access to care, and so on.56 Therefore, CHWs, serve as a 2-way 
liaison between the community and health care system57, can help overcome barriers to 
controlling diabetes. In the United States, CHWs have helped to meet the national health 
goals by conducting community-level activities and interventions that promote health and 
prevent diseases and disability.56 Also, there is ample evidence of their contributions to 
improved health outcomes, especially among those with diabetes.52,58  
Medical consumption of stroke 
Disease manifestation has become more complicated due to changes in modern 
diets and lifestyles. Diabetes and its associated complications are known to have a 
significant relationship on the consumption of healthcare resources.59 Compared to 
non-diabetics, diabetic patients hospitalized for a cardiovascular event incur higher costs 
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for care.60 Following are contributing factors that related to medical consumption of 
stroke. 
Medical expenditure  
When a person suffered a stroke and undergoes emergency care at a medical 
institution during the acute period, to control the patient’s condition, treatment resources 
were needed during the episode period including emergency room, neurology specialists, 
intensive care, rehabilitation and outpatient service. The costs of hospitalizations 
involving stroke are high and vary greatly by type of stroke, diagnosis status, and 
comorbidities.61 The total US healthcare cost of all strokes was estimated at $53.9 billion in 
2010.62 A study indicated that ischemic, hemorrhagic, or other strokes having average 
costs, in turn, of $18,963±$21,454, $32,035±$32,046, and $19,248 ± $21,703, 
respectively.61 
Length of stay 
Dependency in daily life affects length of stay of stroke patients.63 Costs of 
inpatient days were the largest contributor to hospital costs.64 Previous study indicated that 
average medical expenses during the hospital stay is US$8,740 where 62% variance was 
explainable by length of stay.65 In a recent Taiwan study, the average length of stay for 
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stroke was 13.9±14.1 days, and average cost was US$1408.7±US$2084.3. The most 
common length of stay was 5-10 days in 39.5% of all patients, and major cost was from 
US$312.50-US$781.25 resulted from 37.0% of overall and 23.2% of first-ever stroke 
patients.66 In addition, complications such as atrial fibrillation, stroke treatment, and 
subtypes were the significant predictive factors affecting hospital costs and length of 
stay.66 Four factors significantly predicted prolonged hospital stay: older age (>65), 
diabetes mellitus, in-hospital infection, and disability on discharge. Diabetes and 
in-hospital infection are possible targets for interventions to reduce the burden of illness 
and healthcare costs of stroke.32  
Severity of stroke 
The severity of stroke could influence the consumption of medical resources. 
Stroke severity is a strong and reliable predictor of length of stay.67 Severity of illness and 
medical complications were the primary issues causing increased length of stay in stroke 
patients.68 The severity of stroke, clinically rated by the score of National Institutes of 





For patients with hypertension, heart disease, diabetes or high blood cholesterol, 
their disease status is more complicated. Length of stay is also commonly longer.70 A 
study indicated that the significant predictive factors for length of stay were diabetes 
mellitus, atrial fibrillation, recurrence, and stroke subtype.66 Besides, Charlson 
Comorbidity Index (CCI) at the time of hospital admission independently influences the 
length of stay after stroke.70 Another study showed that 75% of patients admitted with 
transient ischemic attack stay in the hospital for ≥ 2 days, with the most important 
determinants being pre-existing medical comorbidities, and longer duration of hospital 




Chapter 3: Methods 
Conceptual Framework 
This study created a model for conceptual framework which retrieved from 
Donabedian model and Andersen healthcare utilization model with little modification. 
(Figure 1)  
The Donabedian model provides a framework for examining health services and 
evaluating quality of health care, which can be drawn from three categories: “structure,” 
“process,” and “outcomes".72 The model assumes that structure (e.g. attributes of material) 
influences process (actually done in receiving care), which affects outcome (e.g. medical 
consumption). The Donabedian model is widely used for both researchers and 
policymakers to conceptualize the mechanisms that may contribute to quality of care for 
diabetic patients. Therefore, this study use “structure-process-outcome” framework 
described by Donabedian73 in order to assess the quality of care for diabetic patients. In 
this study, there was no specific variable in structure part which affect process of care. 
The potential actions in process part was defined by different duration of lapses in 
diabetic ambulatory care for diabetic patients received care. The important indicator for 
quality outcome was defined as consumptions of subsequence ischemic stroke 
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hospitalization which contains expenditure, length of stay and severity. 
The Andersen healthcare utilization model aimed at demonstrating the factors that 
lead to the use of health services. According to the initial Andersen model74, three 
dynamic factors, including predisposing factors, enabling factors and need, will influence 
the utilization of health services by people. In this study, we used the initial Andersen 
model for developing an integrated model. Predisposing factor was defined as patients’ 
characteristics, including age and sex. Enabling factor facilitates individuals to use 
services. It could be low-income status and shared care program for diabetic patients in the 
study. Need factor represents both perceived and actual need for health care services, 




















Consumptions of Index Stroke 
a. Expenditure 
b. Length of stay 
c. Severity 
Process Structure Outcome 








It was known that people with diabetes mellitus were recommended to visit 
physician regularly for diabetes management. DSCP plays a role in structure part to 
influence the duration of lapses in diabetic ambulatory care. Besides, the duration of lapses 
in diabetic ambulatory care among diabetic patients may vary by individual characteristics, 
which including age, sex, low-income status and comorbidities. In other words, individual 
characteristics may influence people’s health care behavior and result in different duration 
of lapses in diabetic ambulatory care. Individual characteristics were represented by 
predisposing factors, enabling factors, and need. Moreover, the different duration of lapses 
in diabetic ambulatory care may further influence the consumption of subsequence 
ischemic stroke, including hospitalized stroke expenditure (H1), length of stay for stroke 
(H2), and severity during stroke hospitalization (H3). Therefore, we assumed that diabetic 
patients with shorter lapses in diabetic ambulatory care before stroke hospitalization may 





In order to test the assumptions that diabetic patients with shorter lapses of 
ambulatory care before stroke hospitalization may reduce the consumption of 
subsequence stroke, three hypotheses for this study were listed below.  
Hypothesis 1: Diabetic patients with shorter lapses of diabetic ambulatory care 
will have lower hospitalized stroke expenditure. 
Hypothesis 2: Diabetic patients with shorter lapses of ambulatory care will have 
shorter length of stay in subsequence stroke. 
Hypothesis 3: Diabetic patients with shorter lapses of ambulatory care will incur 





Study Design and Methods 
Data Source 
To understand the relationship between lapses in diabetic ambulatory care on 
stroke consumption among diabetic patients, we conducted a retrospective cohort study by 
using a longitudinal National Health Insurance Database(NHIRD) from Taiwan.  
Taiwan has launched a compulsory National Health Insurance program since 1995, 
which covers 99% of the population and reimburses for outpatients, inpatients services as 
well as prescription drugs. All contracted institutions must file claims according to 
standard formats which later transform into NHIRD. The data are collected from the 
reimbursement records of the National Health Insurance program in Taiwan, where the 
personal identification information is encrypted, and these data are maintained by the 
National Health Research Institutes for research purposes. 
This study used a specific database that recruited all populations with stroke 
hospitalization and all their medical services. Over the past 15 year, there was little 
reimbursement change in diabetes and stroke care in Taiwan. The accuracy of diagnosis of 
major diseases in the NHIRD, such as diabetes and stroke, had been validated.75-77 With a 
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large and consistency database from Taiwan, it is helpful for understanding the relationship 
between lapses in ambulatory care and stroke medical consumptions in diabetic patients. 
Study Design and Study population 
Previous Taiwanese study found that the ischemic stroke incidence in diabetes 
was 11.4% during 4 year follow-up.78 It is estimated to have more resource and 
expense in order to prospectively follow diabetic patients for subsequence ischemic 
stroke in their life-time. Therefore, this study was a retrospective design in analyzing 
secondary administrative claims from Taiwanese National Health Insurance program 
for calendar year 2002 to 2012. Study population was defined as patients with 
diabetes mellitus and subsequence ischemic stroke hospitalization. 
Patients with diabetes mellitus were identified in the 13th to 24th months prior 
to stroke hospitalization based on following inclusion criteria：patients had at least 
one hospital admission or had at least four times of outpatient visits for 
diabetes-related illness (The International Classification of Diseases, 9th Revision, 
Clinical Modification,(ICD-9-CM) code 250.xx).79,80 (Figure 2) Those patients with 
fewer than four visits in the 12-month period were excluded and considered as 
undetermined diagnosis.79 Besides, it is hard to distinguish type 1 diabetes and type 2 
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diabetes only by diagnose codes. Previous studies suggested to identify patients with 
type 1 DM by using catastrophic registry (ICD-9 codes 250.x1 or 250.x3) in 
Taiwan.81-83 However, the previous results found that the Type 1 DM was present in 
less than 1% of the diabetic population in Taiwan during 2000 to 200981, and the 
incidence rate was 3.34 per 100,000 during 2009 to 2010.82 The latest study only 
identified 4,007 patients with type 1 DM during 1999 to 2012.83 Therefore, this study 
did not distinguish patients with type 1 diabetes and type 2 diabetes. Moreover, based 
on guideline, the diabetic ambulatory care between type 1 diabetes and type 2 
diabetes are not different, so we consider patients with type 1 diabetes and patients 
with type 2 diabetes should have the same pattern of diabetic ambulatory care. We 
also examined all stroke hospitalized patients aged 20 and older with a primary 
diagnosis in ischemic stroke (ICD-9-CM codes 433.x1, 434.x1, 436) for the first time 
between 2002 and 2012. The first ischemic stroke during the study period is defined 
as the index stroke. Those patients with ischemic stroke during 1997 to 2001 were 
also excluded in order to create a wash-out period. Each year, it is about 24,000 
new-onset stroke patients in Taiwan, and about 34% of stroke patients have diabetes 
mellitus.84 The sample size was estimated to have 89,760 diabetic patients with 
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ischemic stroke, which power was equal to 1. This is a nationwide study that included 






Figure 2 Define study population 
 
  
Diabetic patients selected 
The 13th month 
before index stroke 
Observation period 
The index stroke 
hospitalization 
The 24th month 
before index stroke 
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Observation period was defined as 12 months prior to the index stroke 
hospitalization. Main exposure was defined as the last diabetic ambulatory care in 
observation period. According to the ADA guideline, for continuous glucose 
monitoring, patients with diabetes were suggested to visit a doctor at least every three 
months to have a HbA1C testing and to determines whether patients’ glycemic targets 
have been reached and maintained.16 Besides, Taiwan’s National Health Insurance 
has encouraged physicians to use “chronic medication prescriptions” for patients with 
stable chronic diseases. Patients are allowed to refill such prescriptions at community 
pharmacies for a maximum of three months’ supply of medications without revisiting 
the doctor.85 Therefore, we classified the study population into four groups according 
to the duration between the last diabetic ambulatory care and index stroke 
hospitalization: A) diabetic patients had the last diabetic ambulatory care within 90 
days prior to the index stroke, B) diabetic patients had the last diabetic ambulatory 
care within 91 to 180 days prior to the index stroke, C) diabetic patients had the last 
diabetic ambulatory care within 181 to 270 days prior to the index stroke, and D) 
diabetic patients had the last diabetic ambulatory care within 271 to 365 days prior to 
the index stroke. Those diabetic patient with no ambulatory care during the 
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observation period was defined as E) diabetic patients had diabetic ambulatory care 
over 365 days prior to the index stroke.  
Key Measures 
The study variables used in this study were summarized in Table1, including 
variables, description, and data type. Independent variables included duration of 
ambulatory care lapses, which divided into five group, and diabetic care exams. 
Diabetic care exams, including HbA1c test, cholesterol test, eye exam, and urine 
microalbumin test, are used to understand whether diabetic patients received 
recommend care for diabetes mellitus during the observation period. (Appendices 
Table 1) We also collected individual characteristic for related covariates, including 
predisposing factor (age, sex), enabling factors (participating in DSCP and low-income 
status), and need (comorbidities). Comorbidities, including hypertension, 
hyperlipidemia, and atrial fibrillation, ischemic heart disease, stroke history, chronic 
kidney disease and heart failure, were confirmed by ICD-9-CM codes based on more 
than 3 times of outpatient visits before the index stroke or list diagnoses of the index 
stroke. We also calculated number of diabetic care exams, number of emergency room 
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visits due to diabetes and number of hospitalization due to diabetes during observation 
period, and type of medical institution of the index stroke.    
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Table 1 Summary definition of study variables 
Variables Description Data Type 
Independent variables   
A. Duration of ambulatory 
care lapses 
During the observation period, the duration 
between the last diabetic ambulatory care 
and the index stroke were divided into 5 
groups: patients with the last ambulatory 
care within 90 days, patients with the last 
ambulatory care within 91 to 180 days, 
patients with the last ambulatory care within 
181 to 270 days, patients with the last 
ambulatory care within 271 to 365 days, and 
patients with the last ambulatory care over 
365 days.  
Nominal  
B. Diabetic care exams   
- HbA1c test Whether diabetic patients received two or 
more HbA1c tests during observation period 
Dichotomous 
-Cholesterol test Whether diabetic patients received at least 
one cholesterol tests during observation 
period 
Dichotomous 
-Eye exam  Whether diabetic patients received at least 
one dilated eye exam during observation 
period 
Dichotomous 
-Urine microalbumin test  Whether diabetic patients received at least 
one urine microalbumin test during 
observation period 
Dichotomous 
Dependent variables   
Medical consumption of the 
index stroke 
  
-Expenditure  Average hospital cost per day of the index 
stroke 
Continuous 




Table 1 Summary definition of study variables (continued) 
Variables Description Data Type 
-Severity Severity of the index stroke evaluated by the 
Stroke Severity Index (SSI)86, which 
classified into 3 categories: severity 1 
(SSI≤5), severity 2 (SSI> 5 to SSI≤ 13), or 
severity 3(SSI>13)87,88  
Nominal 
Covariates    
Age Patients’ age of the index stroke Continuous 
Sex Patients’ sex Dichotomous 
Low-income status Whether patients were classified low-income 
status in national health insurance 
Dichotomous 
Comorbidities   
-hypertension Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
-hyperlipidemia Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
-atrial fibrillation Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
-ischemic heart disease Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
-stroke history Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 






Table 1 Summary definition of study variables (continued) 
Variables Description Data Type 
-chronic kidney disease Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
-heart failure Whether diabetic patients have more than 3 
times of list diagnoses in outpatient visits 
before the index stroke or list diagnoses of 
index stroke 
Dichotomous 
DSCP Whether diabetic patients ever participated in 
diabetes shared care program 
Dichotomous 
Number of diabetic care 
exams 
The summary of diabetic care exams, 
including HbA1c test, cholesterol test, eye 
exam, and urine microalbumin test, for each 
diabetic patients 
Continuous 
Number of emergency room 
visits due to diabetes 
Number of emergency room visits due to 
diabetes-related disease listed in the primary 
diagnose during observation period which 
classified into three categories: 0, 1, and ≥2 
Nominal 
Number of hospitalization 
due to diabetes 
Number of hospitalization due to 
diabetes-related disease listed in the primary 
diagnose during observation period which 
classified into three categories: 0, 1, and ≥2 
Nominal 
Type of medical institution 
of the index stroke 
The medical institution for diabetic patient 
visited for the index stroke which classified 
into 3 categories: medical center, regional 






Main outcome measures 
The primary outcome of interests in this study is medical expenditure of the 
index stroke. The secondary outcomes are length of stay and severity of index stroke. 
Stroke severity was evaluated by the Stroke Severity Index(SSI), which comprised 
seven claims items including airway suctioning, bacterial sensitivity test, general ward 
stay, intensive care unit stay, nasogastric intubation, osmotherapy, and urinary 
catheterization, developed specifically to evaluate the severity of strokes for Taiwan 
NHIRD.(Appendices Table 2)86 The SSI correlated with admission stroke severity, as 
assessed using the National Institutes of Health Stroke Scale(NIHSS), with a Pearson 
correlation coefficient of 0.74286 and improved case-mix adjustment of mortality 
models in patients with ischemic stroke.88,89 The SSI was categorized as severity 1 
(SSI ≤5), severity 2(SSI> 5 to ≤ 13), or severity 3(SSI > 13) in accordance with prior 
studies.87,88 The study period started from 12 month prior to the index stroke to the 
date of the index stroke hospitalization. 
Statistical analysis 
The distribution of study population within 5 categories of different diabetic 
ambulatory care lapses prior to stroke (patients with the last ambulatory care within 90 
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days prior to stroke, patients with the last ambulatory care within 91 to 180 days prior to 
stroke, patients with the last ambulatory care within 181 to 270 days prior to stroke, 
patients with the last ambulatory care within 271 to 365 days prior to stroke, and patients 
with the last ambulatory care over 365 days prior to stroke) were examined. 
Characteristics of diabetic patients were compared by analysis of variance (ANOVA) test 
for continuous variables and chi-square test for categorical variables, as appropriate. 
Diabetic care exams that patients received prior to the index stroke hospitalization were 
described between five categories of different diabetic ambulatory care lapses. 
The multivariate regression models were used to understand the relationship 
between different lapses in diabetic ambulatory care prior to the index stroke and stroke 
medical consumptions, including medical expenditure and length of stay. The 
relationship between different lapses in diabetic ambulatory care prior to the index stroke 
and stroke severity was analyzed by using multinomial logistic regression model. Patients’ 
age, sex, hypertension, atrial fibrillation, ischemic heart disease, chronic kidney disease, 
heart failure, DSCP, number of diabetic care exams, numbers of emergency room visits 
due to diabetes, numbers of hospitalization due to diabetes, and type of medical institution 
for the index stroke were included in regression models for controlling. Model diagnostics 
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will be used to test regression assumptions. All statistics analyses were performed with 
SAS statistical software, version 9.4 (SAS Institute Inc., Cary, NC). A two-sided p value 
< 0.05 was considered to be statistically significant. 
Human Subjects 
This is a retrospective study. Study population are identified from NHIRD. All 
personal identification data in the NHIRD are encrypted to ensure the confidentiality of 
individuals in order to avoid ethical concerns. The study protocol was approved by the 




Chapter 4: Results 
Characteristics of five study groups 
Among 277,745 eligible patients aged 20 and older suffered from ischemic stroke 
during 2002 to 2012, there were 76,786 patients who had diagnosed diabetes mellitus one 
year prior to stroke. Patients who had missing data in sex or had a length of stay over 120 
days were excluded. Therefore, 76,194 (27.4%) diabetic patients with subsequence stroke 
hospitalization were included for analysis. The selection flow of study population was 
showed in Figure 3. In order to understand how diabetic ambulatory care was managed 
for diabetic patients prior to stroke hospitalization, diabetic patients were divided into 
five groups based on the different duration of diabetic ambulatory care lapses prior to the 
index stroke. The five groups were diabetic patients with the last ambulatory care within 
90 days prior to stroke, diabetic patients with the last ambulatory care within 91 to 180 
days prior to stroke, diabetic patients with the last ambulatory care within 181 to 270 
days prior to stroke, diabetic patients with the last ambulatory care within 270 to 365 
days prior to stroke, and diabetic patients with the last ambulatory care over 365 days 





Figure 3 Flow chart of study population and data management process 
201,551 Excluded 
Diabetes was not found in any discharge 
diagnose position or patients had less than 
twice diabetes visits at clinic or outpatient 
department within 365 days 
277,745 The individuals, aged 20 years older 
with subsequence ischemic stroke 
during 2002~2012 
76,786 Ischemic stroke patients were diagnosed 
diabetes mellitus in 1 year prior to stroke 
hospitalization 
592 Excluded 
Patients had missing data in sex or had a 
length of stay over 120 days 
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More than half (59.1%) of the patients had the last ambulatory care within 90 
days prior to stroke, and more than one-fourth (27.8%) of patients had the last ambulatory 
care over 365 days prior to stroke. Patients had the last ambulatory care within 91 to 180 
days prior to stroke was 6.3%; patients had the last ambulatory care within 181 to 270 
days prior to stroke was 3.7%; patients had the last ambulatory care within 271 to 365 
days prior to stroke was 3.1%. The characteristics of the study population with different 









Table 2 Study population characteristics stratified by different pattern of ambulatory care lapses prior to stroke hospitalization 
  The last ambulatory care prior to stroke  
 Overall ≤ 90 days 91~180 days 181~270 days 271~365 days > 365 days P value 
Characteristic n=76194 n=45049 (59.1) n=4786 (6.3) n=2823 (3.7) n=2335 (3.1) n=21201 (27.8)  
Age, years, Median (IQR) 71 (62-78) 70  (62-77) 70 (61-77) 71 (62-78) 71 (62-78) 73 (63-80) <0.0001 
Age group, n (%)             <0.0001 
  <65 23315 (30.6) 14428 (32.0) 1569 (32.8) 869 (30.8) 725 (31.1) 5724 (27.0)  
  65-74 24586 (32.3) 15613 (34.7) 1591 (33.2) 866 (30.7) 717 (30.7) 5799 (27.4)  
  75-84 22535 (29.6) 12543 (27.8) 1340 (28.0) 888 (31.5) 740 (31.7) 7024 (33.1)  
  ≥85 5758 (7.6) 2465 (5.5) 286 (6.0) 200 (7.1) 153 (6.6) 2654 (12.5)  
Male, n (%) 39991 (52.5) 23241 (51.6) 2544 (53.2) 1482 (52.5) 1189 (50.9) 11535 (54.4) <0.0001 
Low-income status, n (%) 628 (0.8) 493 (1.1) 41 (0.9) 26 (0.9) 29 (1.2) 39 (0.2) <0.0001 
Comorbidities, n (%)              
Hypertension 50869 (66.8) 29971 (66.5) 3430 (71.7) 2108 (74.7) 1733 (74.2) 13627 (64.3) <0.0001 
Hyperlipidemia 23205 (30.5) 15976 (35.5) 1587 (33.2) 876 (31.0) 720 (30.8) 4046 (19.1) <0.0001 
Atrial fibrillation 3725 (4.9) 1611 (3.6) 250 (5.2) 155 (5.5) 180 (7.7) 1529 (7.2) <0.0001 
Ischemic heart disease 18697 (24.5) 9902 (22.0) 1361 (28.4) 858 (30.4) 720 (30.8) 5856 (27.6) <0.0001 
Stroke history 12175 (16.0) 6161 (13.7) 924 (19.3) 591 (20.9) 490 (21.0) 4009 (18.9) <0.0001 
Chronic kidney disease 6685 (8.8) 3042 (6.8) 552 (11.5) 364 (12.9) 328 (14.1) 2399 (11.3) <0.0001 




Table 2 Study population characteristics stratified by different pattern of ambulatory care lapses prior to stroke hospitalization 
(continued) 
  The last ambulatory care prior to stroke  
 Overall ≤ 90 days 91~180 days 181~270 days 271~365 days > 365 days P value 
Characteristic n=76194 n=45049 (59.1) n=4786 (6.3) n=2823 (3.7) n=2335 (3.1) n=21201 (27.8)  
Location of DM visit, by 
type of clinic, n (%) 
            <0.0001 
Hospital-based clinic 35065 (46.0) 28844 (64.0) 2946 (61.6) 1769 (62.7) 150
6 
(64.5) 0 (0)  
Clinics 19928 (26.2) 16205 (36.0) 1840 (38.5) 1054 (37.3) 829 (35.5) 0 (0)  
Number of emergency 
room visit in the previous 
year due to diabetes 
            <0.0001 
  0 71263 (93.5) 40919 (90.8) 4401 (92.0) 2612 (92.5) 2192 (93.9) 21139 (99.7)  
  1 4132 (5.4) 3433 (7.6) 325 (6.8) 185 (6.6) 135 (5.8) 54 (0.3)  
  >=2 799 (1.1) 697 (1.6) 60 (1.3) 26 (0.9) 8 (0.3) 8 (0.04)  
Number of hospitalization 
in the previous year due to 
diabetes 
            <0.0001 
  0 71764 (94.2) 41759 (92.7) 4390 (91.7) 2612 (92.5) 2193 (93.9) 20810 (98.2)  
  1 3606 (4.7) 2653 (5.9) 324 (6.8) 181 (6.4) 115 (4.9) 333 (1.6)  




Patients with longer lapses seemed to be older, and the results showed statistically 
significant difference between groups. The median age of overall study population was 
71 years old. The median age of the five groups ranged from 70 to 73 years old. Patients 
with the last ambulatory care over 365 days prior to stroke had the lowest percentage in 
age less than 65 and age 65 to 74 and had the highest percentage in age 75 to 84 and age 
over 85. Besides, more than half (52.5%) of the overall patients were male in the study. 
There was no trend relationship between ambulatory care lapses and sex although the 
results showed statistically significant difference between groups. The percentage of male 
patients in five groups ranged from 50.9% to 54.4%. Patients with the last ambulatory 
care over 365 days prior to stroke had the highest percentage of male sex. Moreover, 
there was no trend relationship between ambulatory care lapses and low-income status 
although the results showed statistically significant difference between groups. Less than 
1 % of the overall patients in this study was classified a low-income status, while 0.2% to 
1.2% was found in five groups. Patients with the last ambulatory care over 365 days prior 
to stroke had the lowest percentage of low-income status. In summary, the distribution of 
age, sex and low-income status varied between five groups. The results indicated that 
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patients who had the last ambulatory care over 365 days prior to the index stroke were 
older, more male and less low-income status.  
The results showed that comorbidities in hypertension and hyperlipidemia were 
less common among diabetic patients with the longest lapses, and patients with longer 
lapses seemed to have lower percentage of comorbidities in hyperlipidemia. Besides, 
patients with longer lapses seemed to have higher percentage of comorbidities in atrial 
fibrillation, ischemic heart disease, stroke history, chronic kidney disease, and heart 
failure, except the longest lapse group. It was found that about two-thirds (66.8%) of 
overall study population had hypertension. Diabetic patient with the last ambulatory care 
within 181 to 270 day prior to stroke had the highest percentage of hypertension (74.4%), 
and those patients with the last ambulatory care over 365 days prior to stroke had the 
lowest percentage of hypertension (64.3%). For comorbidity in hyperlipidemia, less than 
one-third (30.5%) of overall study population had hyperlipidemia. Diabetic patients with 
the last ambulatory care within 90 days prior to stroke showed the highest percentage in 
hyperlipidemia (35.5%), and those patients with the last ambulatory care over 365 days 
prior to stroke were the lowest percentage (19.1%). In summary, the prevalence of 
comorbidities in hypertension, hyperlipidemia, atrial fibrillation, ischemic heart disease, 
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stroke history, chronic kidney disease, and heart failure varied between five groups. The 
results indicated that patients with the last ambulatory care over 365 days prior to the 
index stroke had less comorbidities in hypertension and hyperlipidemia, whereas patients 
with the last ambulatory care within 90 days prior to the index stroke had less 
comorbidities in atrial fibrillation, ischemic heart disease, stroke history, chronic kidney 
disease, and heart failure.  
More than 60% of patients in each group frequently visited hospital-based clinic 
for diabetic ambulatory care, expect the longest lapse group. Among overall population, 
less than half (46.0%) of patients frequently visited hospital-based clinic for diabetic 
ambulatory care during observation period of 365-days, whereas over one-fourth (26.2%) 
of patients frequently visited clinic. Since 27.8% of diabetic patients had the last diabetic 
ambulatory care over 365 days, the summary percentage of frequently visit location in 
observation period for overall study population were not 100%. The results showed that 
diabetic patients with the last ambulatory care within 271 to 365 days prior to stroke had 
the highest percentage (64.5%) of patients went to hospital-based clinic for ambulatory 
care and the lowest percentage (35.5%) of patients went to clinics. On the other hand, 
patients with the last ambulatory care within 91 to 180 days prior to stroke had the lowest 
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percentage (61.6%) of patients went to hospital-based clinics for diabetic care and the 
highest percentage (38.5%) of patients went to clinics. The results indicated that diabetic 
patients with different diabetic ambulatory care lapses tended to visit hospital-based 
clinic for their diabetic care although the percentage of frequently visited location varied 
between groups.  
During the observation period, diabetic patients with longer lapses seemed to have 
less diabetes-related emergency room visit and less diabetes-related hospitalization visits. 
However, there was no trend relationship between ambulatory care lapses and 
diabetes-related hospitalization visits. Most of study population did not have 
diabetes-related emergency room visit (93.5%) and diabetes-related hospitalization visit 
(94.2%). Diabetic patients with the last ambulatory care within 90 days prior to stroke 
had the highest percentage in diabetic-related emergency room visit (1 time: 7.6%; 2 or 
more times: 1.6%), and those with the last ambulatory care over 365 days prior to stroke 
had the lowest percentage in diabetic-related emergency room visit (1 time: 0.3%; 2 or 
more times: 0.04%). For diabetic-related hospitalization during 365 days prior to stroke, 
diabetic patients with the last ambulatory care within 91 to 180 days prior to stroke had 
the highest percentage in diabetic-related hospitalization (1 time: 6.8%; 2 or more times: 
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1.5%), and those with the last ambulatory care over 365 days had the lowest percentage 
in diabetic-related hospitalization (1 time: 1.6%; 2 or more times: 0.3%). The results 
showed that diabetes-related emergency room visit and hospitalization visits varied 
between five groups. Diabetic patients with longer lapses prior to stroke tended to have 
less emergency room visit and hospitalization visit due to diabetes.  
In summary, the study results found that diabetic patients with the last ambulatory 
care over 365 days prior to stroke were older, more male, having more highly 
symptomatic comorbidities, such as atrial fibrillation, ischemic heart disease, stroke 
history, chronic kidney disease, and heart failure, and having less diabetic-related 
emergency visit and hospitalization when compare to those with the last ambulatory care 





Utilization of diabetic care exams in five study groups 
According to Table 3, patients with longer lapses seemed to have lower 
percentage in DSCP participation and in diabetic care exams. It was found that 13.7% of 
overall population had participated DSCP, and the percentage of four diabetic care exams 
ranged from 27.7% to 59.5%. The participating rate for DSCP and receiving diabetic care 
exams varied between 5 groups. Diabetic patients with the last ambulatory care within 90 
days prior to stroke had the highest percentage (20.8%) in participating in DSCP, and 
those patients with the last ambulatory care over 365 days prior to stroke had the lowest 
percentage (0.6%). It was found that diabetic patients with shorter lapses before the index 
stroke had higher participating rate in DSCP. For four kinds of diabetic care exams in 365 
days prior to the index stroke, diabetic patients with the last ambulatory care within 90 
days had the highest percentage in having two or more HbA1c test (63.3%), having 
cholesterol test (67.0%), having dilated eye exam (35.2%), and having a urine routine test 
(36.2%), whereas diabetic patients with the last ambulatory care over 365 days had the 
lowest percentage in having two or more HbA1c test (24.5%), having cholesterol test 
(43.4%), having dilated eye exam (14.6%), and having a urine routine test (11.3%). It 
seemed that diabetic patients with longer lapses before the index stroke had lower 
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percentage to receive 4 kinds of diabetic care exams. In summary, the results showed that 
diabetic patients with the last ambulatory care over 365 days were associated with the 
lowest percentage in DSCP participation and the lowest percentage in receiving diabetic 




Table 3 Diabetic care exams prior to stroke hospitalization stratified by different pattern of ambulatory care lapses  
  The last ambulatory care prior to stroke  
 Overall ≤ 90 days 91~180 days 181~270 days 271~365 days > 365 days P value 
Participation in DSCP 10448 (13.7) 9352 (20.8) 614 (12.8) 216 (7.7) 136 (5.8) 130 (0.6) <0.0001 
Diabetic care exams, n (%)              
Having HbA1c tests in the 
past year 
38311 (50.3) 28526 (63.3) 2436 (50.9) 1254 (44.4) 907 (38.8) 5188 (24.5) <0.0001 
Having cholesterol test in the 
past year 
45322 (59.5) 30182 (67.0) 2987 (62.4) 1701 (60.3) 1250 (53.5) 9202 (43.4) <0.0001 
Having dilated eye exam in 
the past year  
21609 (28.4) 15871 (35.2) 1366 (28.5) 740 (26.2) 548 (23.5) 3084 (14.6) <0.0001 
Having urine microalbumin 
/urine routine test in past year 





Medical utilization of the index stroke in five study groups 
Medical utilization of the index stroke in diabetic patients between five groups 
were displayed in Table 4. The most frequent medical institution for index stroke visiting 
were regional hospital, and followed by medical center and district hospital. There was 
no trend relationship between ambulatory care lapses and type of medical institution for 
index stroke although the results showed statistically significant difference between 
groups. Patients with longer lapses seemed to have longer length of stay, higher average 
hospitalization cost per day, and severer stroke although there were no trend relationships 
between lapses of diabetic ambulatory care and stroke medical consumptions. Besides, 
patients with longer lapses seemed to have higher percentage of patients with in-hospital 
death and discharge under critical condition.  
The results showed that less than half (47.7% to 48.9%) of patients visited 
regional hospital for the index stroke, 29.5% to 32.6% of patients visited medical center, 
and 19.7% to 22.4% of patients visited district hospital. Patients with the last ambulatory 
care within 90 days prior to stroke had the highest percentage to visit medical center 
(32.6%) and the lowest percentage to visit regional hospital (47.7%) and district hospital 
(19.7%) when they suffered from ischemic stroke. Besides, the median length of stay for 
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the index stroke were 8 days (IQR 5-16) in overall patients. Diabetic patient with the last 
ambulatory care within 90 days had a shorter length of stay and small IQR when 
compared to other groups. Moreover, the median of average hospitalization cost per day 
for the index stroke was 4,303 New Taiwan Dollar (NTD) (IQR 3,316- 5,834). Diabetic 
patients with the last ambulatory care within 90 days prior to stroke had the lowest 
average hospitalization cost (4,251 NTD), whereas those with the last ambulatory care 
over 365 days had the highest hospitalization cost (4,417 NTD). For severity of the index 
stroke, 64.6% of study patients were in stroke severity 1; 15.1% of study patient were in 
stroke severity 2; and 20.3% of study patients were in stroke severity 3. Diabetic patients 
with the last ambulatory care within 90 days had the highest percentage in stroke severity 
1 and the lowest percentage in stroke severity 2 and stroke severity 3, whereas diabetic 
patients with the last ambulatory care over 365 days had the lowest percentage in stroke 
severity 1 and the highest percentage in stroke severity 2 and stroke severity 3.  
The index stroke caused 2.7% of study patients had in-hospital death and 1.9% of 
study patients discharged under critical condition. Diabetic patients with the last 
ambulatory care within 90 days had the lowest percentage of in-hospital death (2.2%) and 
discharge under critical condition (1.6%), whereas those with the last ambulatory care 
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over 365 days had the highest percentage of in-hospital death (3.7%) and discharge under 
critical condition (2.3%). 
In summary, the results showed that diabetic patients with the last ambulatory 
care over 365 seemed to have longer length of stay, higher average hospitalization cost 
for the index stroke, higher severity of stroke, and more critical condition when 




Table 4 Medical utilization of index stroke in diabetic patients 
  The last ambulatory care prior to stroke  
 Overall ≤ 90 days 91~180 days 181~270 days 271~365 days > 365 days P value 
Medical institution type for 
stroke hospitalization, n 
(%) 
            <0.0001 
Medical center 24056 (31.6) 14689 (32.6) 1471 (30.7) 833 (29.5) 701 (30.0) 6362 (30.0)  
Regional hospital 36580 (48.0) 21474 (47.7) 2305 (48.2) 1359 (48.1) 1141 (48.9) 10301 (48.6)  
District hospital 15558 (20.4) 8886 (19.7) 1010 (21.1) 631 (22.4) 493 (21.1) 4538 (21.4)  
Length of stay, median 
(IQR) 
8 (5-16) 8 (5-15) 8 (5-17) 8 (5-16) 9 (5-17) 9 (5-17) <0.0001 
Average hospitalization 














Stroke severity              <0.0001 
1 (SSI≤5) 49252 (64.6) 30736 (68.2) 3000 (62.7) 1792 (63.5) 1423 (60.9) 12301 (58.0)  
2 (5<SSI≤ 13) 11494 (15.1) 6489 (14.4) 745 (15.6) 442 (15.7) 379 (16.2) 3439 (16.2)  
3 (SSI>13) 15448 (20.3) 7824 (17.4) 1041 (21.8) 589 (20.9) 533 (22.8) 5461 (25.8)  
Outcomes of index stroke              
In-hospital death 2088 (2.7) 1010 (2.2) 147 (3.1) 75 (2.7) 79 (3.4) 777 (3.7) <0.0001 
Discharge under critical 
condition 




Factors associated with average hospitalization cost per day 
The results showed that average hospitalization cost per day was 1.03% higher for 
diabetic patients with the last ambulatory care over 365 days (p<0.0001) compared to 
those patients with the last ambulatory care within 90 days. Table 5 also showed that 
factors in age, hypertension, atrial fibrillation, ischemic heart disease, stroke history, 
chronic kidney disease, heart failure, participating in DSCP, and medical institution for 
stroke were associated with average hospitalization cost per day derived from 
multivariate regression analysis.  
By age factors, average hospitalization cost per day was 1.01% statistically 
significant higher among diabetic patients aged 65 to 74 years old (p=0.0101), 1.02% 
statistically significant higher among diabetic patients aged 75 to 84 years old (p<0.0001), 
and 1.06% statistically significant higher among diabetic patients aged 85 and older 
(p<0.0001) when comparing to those aged under 65 years old. No statistically significant 




Table 5 The multivariate regression between logarithm average hospital cost per day and 
diabetic patients with different pattern of lapses 
 Natural log average hospital cost per day 
Parameter  Estimate  Standard Error t value Pr > |t| 
The last ambulatory care prior to 
stroke (compared to ≤ 90 days) 
    
91~180 days 0.01 0.01 1.40 0.1618 
181~270 days -0.003 0.01 -0.35 0.7245 
271~365 days 0.01 0.01 0.73 0.4629 
> 365 days 0.03 0.004 6.15 <0.0001 
Age (compared to age<65 years 
old) 
    
65-74 0.01 0.004 2.57 0.0101 
75-84 0.02 0.004 5.00 <0.0001 
>=85 0.06 0.007 8.34 <0.0001 
Male -0.0009 0.003 -0.26 0.7986 
Comorbidities     
Hypertension 0.01 0.004 2.46 0.0141 
Atrial fibrillation 0.11 0.008 13.61 <0.0001 
Ischemic heart disease 0.03 0.004 5.98 <0.0001 
Stroke history -0.02 0.005 -5.26 <0.0001 
Chronic kidney disease 0.19 0.006 31.63 <0.0001 
Heart failure 0.08 0.006 12.35 <0.0001 
Participated in DSCP -0.02 0.006 -4.26 <0.0001 




Table 5 The multivariate regression between logarithm average hospital cost per day and 
diabetic patients with different pattern of lapses (continued) 
 Log average hospital cost per day 
Parameter  Estimate  Standard Error t value Pr > |t| 
Number of emerge visit due to DM     
1 -0.002 0.008 -0.26 0.7942 
≥2 -0.02 0.02 -1.15 0.2502 
Number of hospitalization due to 
DM 
    
1 0.007 0.008 0.92 0.3584 
≥2 -0.02 0.02 -1.31 0.1918 
Type of medical institution for 
index stroke 
    
Medical center 0.25 0.005 52.71 <0.0001 
Regional hospital 0.18 0.004 40.17 <0.0001 
Intercept 8.19 0.006 1308.59 <0.0001 
 N=76194    P value <0.0001 






By comorbidity factors, average hospitalization costs were statistically significant 
higher among diabetic patients with hypertension (1.01%, p=0.0141), atrial fibrillation 
(1.12%, p<0.0001), ischemic heart disease (1.03%, p<0.0001), chronic kidney disease 
(1.21%, p<0.0001), heart failure (1.08%, p<0.0001), and statistically significant lower 
among those with stroke history (0.98%, p<0.0001). Diabetic patients participating in 
DSCP were more likely to have a lower average hospitalization cost per day (0.98%, 
p<0.0001). No statistically significant association existed for average hospitalization cost 
by numbers of diabetic care exams, numbers of emerge visits due to diabetes, and number 
of hospitalization visit due to diabetes within 365 days before the index stroke.  
By reported medical institution for stroke care, average hospitalization cost was 
statistically significant higher among diabetic patients who visited medical center (1.29%, 




Factors associated with length of stay 
The multivariate regression results of factors associated with stroke length of stay 
are exhibited in Table 6. Compared to diabetic patients with the last ambulatory care 
within 90 days, length of stay were statistically significant 0.79 days longer in those with 
the last ambulatory care within 91 to 180 days, 1.05 days longer in those with the last 
ambulatory care within 271 to 365 days, and 0.65 days longer in those with the last 
ambulatory care over 365 days. Length of stay was longer for diabetic patients with 
longer lapses compared to those with shortest lapses although there was not statistically 
significant in those with the last ambulatory care within 181 to 270 day.  
By age factors, length of stay was 1 days statistically significant longer among 
diabetic patients aged 65 to 74 years old, 2.18 days statistically significant longer among 
diabetic patients aged 75 to 84 years old, and 3.36 days statistically significant longer 
among diabetic patients aged 85 and older when comparing to those aged under 65 years 
old. Male sex of diabetic patients was more likely to have a shorter length of stay for the 




Table 6 The multivariate regression between length of stay and diabetic patients with 
different lapses 
 length of stay 
Parameter  Estimate  Standard Error t value Pr > |t| 
The last ambulatory care prior to 
stroke (compared to ≤ 90 days) 
    
91~180 days 0.79 0.22 3.68 0.0002 
181~270 days 0.32 0.28 1.15 0.2510 
271~365 days 1.05 0.30 3.47 0.0005 
> 365 days 0.65 0.13 4.94 <0.0001 
Age (compared to age<65 years old)     
65-74 1.00 0.13 7.65 <0.0001 
75-84 2.18 0.14 16.11 <0.0001 
>=85 3.36 0.21 15.73 <0.0001 
Male -0.30 0.10 -2.91 0.0036 
Comorbidities     
Hypertension -0.28 0.11 -2.48 0.0130 
Atrial fibrillation 3.09 0.25 12.33 <0.0001 
Ischemic heart disease -0.12 0.13 -0.91 0.3618 
Stroke history 0.88 0.14 6.19 <0.0001 
Chronic kidney disease 0.96 0.19 5.11 <0.0001 
Heart failure 1.92 0.19 10.31 <0.0001 
Participated in DSCP 0.04 0.17 0.21 0.8343 




Table 6 The multivariate regression between length of stay and diabetic patients with 
different lapses (continued) 
 length of stay 
Parameter  Estimate  Standard Error t value Pr > |t| 
Number of emerge visit due to DM     
1 1.11 0.23 4.78 <0.0001 
≥2 1.48 0.51 2.89 0.0039 
Number of hospitalization due to DM     
1 1.51 0.25 6.04 <0.0001 
≥2 2.32 0.51 4.58 <0.0001 
Type of medical institution for index 
stroke 
    
Medical center 5.15 0.15 34.99 <0.0001 
Regional hospital 2.46 0.14 18.08 <0.0001 
Intercept 9.02 0.19 47.12 <0.0001 
 N=76194   P value <0.0001 







By comorbidity factors, there were no statistically significant association between 
length of stay and hypertension (-0.28 day, p=0.0130) and ischemic heart disease (-0.12 
day, p=0.3618). Length of stay were statistically significant longer among diabetic 
patients with atrial fibrillation (3.09 days, p<0.0001), stroke (0.88 day, p<0.0001), 
chronic kidney disease (0.96 day, p<0.0001), and heart failure (1.92 days, p<0.0001). No 
statistically significant association existed for length of stay by diabetic patients 
participating in DSCP (0.04 days, p=0.8343). Diabetic patients with receiving more 
diabetic care exams in 365 days before the index stroke were more likely to have a lower 
length of stay (-0.16 days, p=0.0006). Length of stay were statistically significant longer 
among diabetic patients with 1-time emergency room visit due to diabetes in 365 days 
before the index stroke (1.11 days, p<0.0001) and with 2 or more times emergency room 
visits due to diabetes in 365 days before the index stroke (1.48 days, p=0.0039) when 
compared to those with no emergency room visit. Length of stay were statistically 
significant longer among diabetic patients with 1-time hospitalization visit due to 
diabetes in 365 days before the index stroke (1.51 days, p<0.0001) and with 2 or more 
hospitalization visits due to diabetes in 365 days before the index stroke (2.32 days, 
p<0.0001) when compared to those with no hospitalization visit. 
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By reported medical institution for stroke care, length of stay was statistically 
significant higher among diabetic patients who visited medical center (5.15 days, 





Factors associated with the index stroke severity 
Table 7 showed multivariable logistic regression results of factors associated with 
the index stroke severity. Stroke severity was statistically significant severer associated 
with diabetic patients with the last ambulatory care within 91 to 180 days, diabetic 
patients with the last ambulatory care within 271 to 365 days, and diabetic patients with 
the last ambulatory care over 365 days when compared to those with the last ambulatory 
care within 90 days.  
By age factors, stroke severity was statistically significant severer for diabetic 
patients who aged 65 to 74 (severity 2 vs. severity 1: OR=1.18, 95%CI:1.12-1.24; 
severity 3 vs. severity 1: OR=1.62, 95%CI: 1.54-1.71), aged 75 to 84 (severity 2 vs. 
severity 1: OR=1.52, 95%CI:1.44-1.60; severity 3 vs. severity 1: OR=2.56, 95%CI: 
2.43-2.70), and aged over 85 (severity 2 vs. severity 1: OR=2.10, 95%CI:1.93-2.28; 
severity 3 vs. severity 1: OR=4.59, 95%CI: 4.27-4.94), when compare to patients aged 
less than 65. The results showed a trend relationship between stroke severity and age. 
Compared to female sex, male sex was statistically significant less severe for 
subsequence stroke(severity 2 vs. severity 1: OR=0.72, 95%CI:0.70-0.76; severity 3 vs. 
severity 1: OR=0.81, 95%CI: 0.78-0.84).  
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Table 7 Estimated odds ratios from multivariable multinomial logistic regression 









The last ambulatory 
care prior to stroke 
    
≤ 90 days 1.00   1.00   
91~180 days 1.123 1.031 1.224 1.239 1.146 1.340 
181~270 days 1.067 0.957 1.190 1.088 0.983 1.203 
271~365 days 1.133 1.006 1.275 1.203 1.080 1.340 
> 365 days 1.144 1.086 1.204 1.343 1.282 1.407 
Age       
<65 1.00   1.00   
65-74 1.179 1.118 1.244 1.618 1.535 1.707 
75-84 1.518 1.438 1.603 2.558 2.428 2.696 
>=85 2.095 1.927 2.278 4.590 4.268 4.937 
Sex       
Female 1.00   1.00   
Male  0.724 0.695 0.755 0.808 0.778 0.839 
Comorbidities       
Hypertension  0.955 0.912 1.000 0.938 0.899 0.979 
Atrial fibrillation 1.473 1.330 1.630 2.266 2.093 2.455 
Ischemic heart 
disease 
0.964 0.916 1.015 1.065 1.018 1.115 
Stroke 1.317 1.246 1.391 1.345 1.280 1.414 
Chronic kidney 
disease 
1.113 1.033 1.200 1.390 1.304 1.481 
Heart failure  1.256 1.166 1.353 1.789 1.684 1.901 
Participated in DSCP 0.972 0.905 1.044 0.940 0.878 1.006 
Number of diabetic 
care exams 
0.917 0.900 0.935 0.896 0.880 0.912 
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Table 7 Estimated odds ratios from multivariable multinomial logistic regression 
(continued) 









Number of emerge 
visit due to diabetes 
      
0 1.00   1.00   
1 1.200 1.095 1.313 1.305 1.202 1.417 
2 or more  1.219 0.995 1.493 1.532 1.289 1.821 
Numbers of hospital 
visit due to diabetes  
      
0 1.00   1.00   
1 1.213 1.099 1.339 1.546 1.419 1.683 
2 or more  1.295 1.060 1.582 1.701 1.434 2.018 
Medical institution for 
the index stroke 
      
District hospital 1.00   1.00   
Regional hospital 0.831 0.789 0.876 1.195 1.135 1.259 





By comorbidity factors, diabetic patients with comorbidities in hypertension had 
lower odds in severity 3 of stroke (OR=0.94, 95%CI: 0.90-0.98), and lower odds in 
severity 2 of stroke (OR=0.96, 95%CI: 0.91-1.00) when compared to severity 1 of stroke, 
though the letter was not statistically significant. Diabetic patients with comorbidities in 
atrial fibrillation (severity 2 vs. severity 1: OR=1.47, 95%CI:1.33-1.63; severity 3 vs. 
severity 1: OR=2.27, 95%CI: 2.09-2.46), stroke history (severity 2 vs. severity 1: 
OR=1.37, 95%CI:1.25-1.39; severity 3 vs. severity 1: OR=1.35, 95%CI: 1.28-1.41), 
chronic kidney disease (severity 2 vs. severity 1: OR=1.11, 95%CI:1.03-1.20; severity 3 
vs. severity 1: OR=1.39, 95%CI: 1.30-1.48), and heart failure (severity 2 vs. severity 1: 
OR=1.26, 95%CI:1.17-1.35; severity 3 vs. severity 1: OR=1.79, 95%CI: 1.68-1.90) were 
associated with higher odds in stroke severity 2 and stroke severity 3 when compared to 
severity 1 of stroke. Diabetic patients with ischemic heart disease had higher odds in 
severity 3 (OR=1.07, 95%CI: 1.02-1.12), and lower odds in severity 2 (OR=0.96, 95%CI: 
0.92-1.02) when compared to severity 1 of stroke, though the letter was not statistically 
significant. No statistically significant association existed for stroke severity and 
participating in DSCP. Stroke severity was statistically significant associated with 
number of diabetic care in 365 days before the index stroke. Diabetic patients with 
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increased diabetic care exams had statistically significant lower odds in severity 2 
(OR=0.92, 95%CI: 0.90-0.94), and severity 3 (OR=0.90, 95%CI: 0.88-0.91) when 
compared to severity 1 of stroke.  
Diabetic patients with 1-time emergency room visit due to diabetes in 365 days 
prior to stroke had statistically significant higher odds in stroke severity 3 (OR=1.31, 
95%CI: 1.20-1.42) and stroke severity 2 (OR=1.20, 95%CI: 1.10-1.31) when compared 
to severity 1 of stroke. Diabetic patients with 2 or more emergency room visit due to 
diabetes had statistically significantly higher odds in stroke severity 3 (OR=1.53, 95%CI: 
1.29-1.82) and stroke severity 2 (OR=1.22, 95%CI: 0.99-1.49) when compared to 
severity 1 of stroke, though the latter was not statistically significant. Stroke severity was 
significantly higher associated with diabetic patients who had 1-time hospitalization visit 
(severity 2 vs. severity 1: OR=1.21, 95%CI:1.10-1.34; severity 3 vs. severity 1: OR=1.55, 
95%CI: 1.42-1.68), and two or more hospitalization visits (severity 2 vs. severity 1: 
OR=1.30, 95%CI:1.06-1.58; severity 3 vs. severity 1: OR=1.70, 95%CI: 1.43-2.02) due 
to diabetes in 365 days prior to stroke when compare to those who had no hospitalization 
visit due to diabetes. 
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By reported medical institution for stroke care, diabetic patients who visited 
medical center were more likely with higher odds in stroke severity 3 (OR=1.48, 95%CI: 
1.40-1.56) when compared to severity 1 of stroke, though odds in stroke severity 2 
(OR=0.99, 95%CI: 0.94-1.05) was not statistically significant. Diabetic patients who 
visited regional hospital were more likely with higher odds in severity 3 (OR=1.20, 
95%CI: 1.14-1.26), and lower odds in severity 2 (OR=0.83, 95%CI: 0.79-0.88) when 




Chapter 5: Discussion of results and policy implications 
This study identified consistent results with previous studies in several aspects for 
diabetic patients with subsequence stroke. Among ischemic stroke patients, this study 
identified 27.4% (n=76,194) of patients with diagnosed diabetes mellitus. The percentage 
is consistent with a previous hospital-based study that reported 27.3% of ischemic stroke 
patients with diabetes.69 A national study examined the quality of care and outcomes in 
patients with diabetes hospitalized with ischemic stroke by using data from Get With the 
Guidelines–Stroke program, and indicated that there were 31% ischemic stroke patients 
with diabetes90. Another research form Taiwan Stroke Registry pointed out that 45.4% of 
stroke patients had diabetes mellitus.20 The differences may come from a 365-day 
exposure period in our study, so stroke patients with first diabetes diagnosed in this 
period or during the stroke hospitalization were not included in this study. Also, this 
study did not include stroke patient with transient ischemic attack.  
The percentage of diabetic patients with no ambulatory visit for 365 days is also 
consistent with previous study. In this study, we found that 27.8 % of diabetic patient had 
no diabetic ambulatory visit in 365 days prior to the index stroke. Similarly, another study 
in Bhutan indicated that near one-third of DM patients did not visited the clinic at least 
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once within a year of registration in National Diabetes Control Programme.91 Also, a 
previous study tried to determine the frequency and correlates of persistent, long-term 
gaps in diabetes care which used “persistent gap” to define diabetic patients persistently 
fail to get recommended care. The result found that 30% of diabetic patients had at least 1 
persistent gap for not receiving preventive services over the 3-year analytic period.92 It 
was known that diabetes control may be accompanied by more frequent medical visits 
which linked with better control of diabetes mellitus93-96, but we found more than 





The characteristics of different diabetic ambulatory lapses groups 
The result of median age (age: 71 ) in this study is consisting with a previous U.S. 
study focused on ischemic stroke patients with diabetes (age: 69.8).90 The results of this 
study showed that diabetic patients with the last ambulatory care within 90 days were 
younger and had a lower percentage of patients aged 75 and older, whereas diabetic 
patients with the last ambulatory care over 365 days had a higher percentage of patients 
aged 75 and older. Age is an important factor in health care utilization, especially for those 
who are older than 65 years. A study profiled older adults receiving assistance with 
physician visits and prescribed medications, and the results found that older adults 
receiving help with both physician visits and prescribed medications typically have high 
health and functioning needs.97 Another study pointed out that nearly one-third (31.3%) of 
community-dwelling adults aged 65 and older were accompanied during routine physician 
visits, and older adults’ companions were overwhelmingly family members (93.3%).98 
Besides, a recent study assessed the association between loneliness and physician visits 
among community-dwelling older adults in Singapore. The study indicated a significant 
association between loneliness and lower odds of physician visits.99 Older population may 
have a higher probability to suffer a serious household medical event (e.g. heart attack), 
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shift in family structure (e.g. death of a partner), or desire to reduce aging associated 
functional decline which result in ambulatory care unaccompanied and longer ambulatory 
care lapses. A recent study investigated knowledge of modifiable cardiometabolic risk 
factors among rural men in the western United States and identify their concerns related to 
heart health and motivation to reduce risk. The results found that catalysts for behavior 
change included a serious medical event in the household and desire to reduce 
aging-associated functional decline.100  
Hypertension is the most common comorbidity for diabetic patients in this study 
(66.8%) which is consistent with other studies. Two Canadian studies reported that 
hypertension was the most common comorbid disease in older adults with diabetes (79.1% 
and 83%)101,102. However, the percentage of diabetic patients with hypertension was lower 
in this study when compared to other studies. The reason may be that this study included 
patients aged 18 to 65 years which increased the population size. Besides, our study has a 
strict definition for comorbidities, which were defined by more than 3 times of list 
diagnoses in outpatient visits before the index stroke or list diagnoses of index stroke, and 
led to a lower percentage of hypertension. In this study, diabetic patients with the last 
ambulatory care within 90 days had the highest percentage in hyperlipidemia (35.5%) 
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when compared to the rest of groups. It seemed that there was a trend relationship between 
ambulatory care lapses and hyperlipidemia. However, there was no trend relationship in 
other comorbidities, such as atrial fibrillation, ischemic heart disease, stroke history, 
chronic kidney disease, and heart failure, although diabetic patients with the last 
ambulatory care within 90 days had the lowest percentage. Because of the characteristic of 
claim data, data was recorded because patients visited physicians for their needs. It is 
possible that patients visit physician for highly symptomatic disease, which take priority to 
record. This situation may result in an overestimate of other disease, which have no 
immediate effects. When compared to other comorbidities in this study, hyperlipidemia 
seemed to have no immediate effects to diabetic patients. It is known that comorbidity 
includes conditions that are highly symptomatic with large effects (e.g., ischemic heart 
disease) and those that have no immediate effects (e.g., hyperlipidemia),103 and 
comorbidities with highly symptomatic are usually recorded by clinical practitioners. 
Comorbidities in this study were defined according to clinic visits or hospitalizations, so 
the results may reflect the real world situation. 
Patients with poorly controlled diabetes mellitus may present repeatedly to the 
emergency department for management and treatment of hyperglycemic. A newly study 
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from Canada identified risk factors that predict unplanned recurrent emergency department 
visits for hyperglycemia in patients with diabetes within 30 days of initial presentation.104 
The result found that patients with a previous hyperglycemia visit in the past month were 
associated with an increased emergency room visit which is similar with our study showed 
that more emergency room visits were observed in diabetic patients with shorter 
ambulatory care lapses. Besides, less diabetes-related emergency room visits and 
hospitalizations were observed in diabetic patients with longer ambulatory care lapses in 
this study. Diabetic patients with shorter ambulatory care lapses did not indicate taking 
medication regularly and having well-controlled diabetes. A recent study identified 
medication adherence trajectories among patients with newly diagnosed diabetes, and 
found that the persistent adherence trajectory only accounted for 39.9% of the subjects.105 
For diabetic patients with poor blood sugar control, they may visit ambulatory care more 
often, and physicians may recommend or transfer these patients to emergency room or 
hospitalization for serious condition. On other hand, diabetic patients with longer lapses 




Utilization for diabetic care exams 
The percentage of patients participating in DSCP, HbA1c test, and cholesterol test 
in this study were different with previous study, but the percentage of dilated eye test and 
microalbumin test in this study were consistent with previous studies. The results of this 
study in Table 3 showed that 13.7% of patients were participating in DSCP, 50.3% of 
patients were having two or more HbA1c test, 59.5% of patients were having cholesterol 
test, and 28.4% of patients were having dilated eye exam among overall study population. 
Besides, diabetic patients with shorter ambulatory care lapses had a higher percentage of 
patients participated in the DSCP, and received diabetic care exam in HbA1c test, 
cholesterol test, dilated eye test, and microalbumin/urine routine test. It is known that 
diabetic patients participating in DSCP are required to attend a clinic or hospital every 3 
months for adjustment of drugs by a physician, and to receive diabetes education from a 
diabetes educator, as well as a diet consultation with a dietitian.6 Therefore, patients with 
ambulatory care lapses less than 90 days is possible to be observed a higher percentage of 
patients who participated in the DSCP, as well as received diabetic care exams in HbA1c 
test, cholesterol test, dilated eye test, and microalbumin/urine routine test.  
78 
 
A small study examined the relationship between medication adherence and 
healthcare outcomes, and the DSCP enrollment rate was 6%.106 Besides, a recently study 
examined the trends of healthcare use and costs for patients with type 2 diabetes mellitus in 
Taiwan, and indicated that about 19% of diabetic patients were enrolled in DSCP.79 The 
percentage of DSCP in this study (13.7%) is higher than the small study, but lower than 
recent study. The reason may be that the population of the small study only focused on 
patients with newly diagnosed type 2 diabetes mellitus. The difference between this study 
and the recently study may come from different definition and calculation. However, the 
percentage of DSCP participation rate in diabetic patients with the last ambulatory care 
within 90 days prior to stroke (20.8%) is similar with the recently study.  
A previous study analyzed claim data to understand accountability and utilization 
of health resources during 2000 to 2009 among diabetic patients in Taiwan.107 The 
percentage of HbA1c test in previous study (67.6%) is higher than our study (50.3%), but it 
is close to patients in diabetic patients with the last ambulatory care within 90 days prior to 
stroke (63.3%). The reason may be come from that previous study identified diabetic 
patients and calculated the utilization in the same period, but diabetic patients were 
identified a year before calculating period. Beside, our study showed a lower percentage of 
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cholesterol test (59.5%) when compare to the percentage of total cholesterol test in the 
previous study (79.1%). The different may come from that we used strict definition in 
calculating cholesterol test, such as total cholesterol test, triglyceride test, and low-density 
lipoprotein cholesterol test should prescribe in the same order. The percentage of dilated 
eye test in previous study is similar with our study (28.4%), and patients with the last 
ambulatory care within 90 days prior to stroke had a higher percentage (35.2%) in 
receiving dilated eye test. The percentage of microalbumin test in our study (27.7%) was 
similar with previous study (25.6%), and patients with the last ambulatory care within 90 
days prior to stroke had a higher percentage (36.2%).  
In other hands, the results indicated that diabetic patients with the last ambulatory 
care over 365 days were associated with a lower participation rate in DSCP and a lower 
percentage to receive diabetic care exams. That is to say, this group of patients did not have 
diabetic ambulatory care, but they received some kinds of diabetic care exams. The reason 
may be that they visited other specialties due to other sever disease, and diabetic care 
exams were provided by other specialties. With further investigation in patent with the last 
ambulatory care over 365 days, we found that diabetic care exams were frequently 
provided through ambulatory care. The primary disease for executing diabetic care exams 
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included hypertensive disease, chronic kidney disease, chronic ischemic heart disease, 
senile cataract, diabetic retinopathy, and glaucoma. Since diabetes management is 
well-established, many specialties are trained to provide appropriate diabetes management 
for diabetic patients. With involving in more specialties in providing diabetes care, it is 





Expenditure of different diabetic ambulatory lapse groups  
The median of average hospitalization cost per day (4,303 NTD =143 USD) was 
higher than previous Taiwanese study, which found that the mean hospitalization cost is 
1532.60 USD per person with mean length of stay for 15.7 days.66 The difference may 
come from that the Taiwanese study was a hospital-based study and study subjects 
comprised patients with first-ever stroke and recurrent stroke.  
Diabetic patients with the last ambulatory care over 365 day had the highest 
median of average hospitalization cost per day while those with the last ambulatory care 
within 90 days had the lowest. Although we had controlled for age, sex, comorbidities in 
hypertension, atrial fibrillation, ischemic heart disease, chronic kidney disease, heart 
failure, participated in DSCP, number of diabetic care exams, number of diabetes-related 
emergency room, number of diabetes-related hospitalization visit, and type of medical 
institution for the index stroke, our multivariate adjusted analyses detected no association 
with average hospitalization cost per day in patients with the last ambulatory care within 
90 days, patients with the last ambulatory care within 91 to 180 days, patients with the 
last ambulatory care within 181 to 270 days, and patients with the last ambulatory care 
within 271 to 365 days. It is possible that neurologists treat their patients according to 
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their professional knowledge and clinical guideline, and the standard for stroke care were 
similar in Taiwan. Many evidence-based stroke care guidelines have been updated in 
accordance with these considerations to successfully guide clinical practice procedures 
for stroke.108-111  
However, the result of this study showed that a statistically significant increased 
average hospitalization cost per day were found in diabetic patients with the last 
ambulatory care over 365 days while controlling all confounding factors. A previous 
study pointed out that lapses in Medicaid coverage can result in inadequate access to care 
and may be associated with overall greater expenditure in the post-lapse periods. The 
result also found that the longer the length of the lapse was negatively associated with the 
likelihood of any total expenditure within a 3-month post-lapse time period.112 The 
difference between the previous study and this study may be that ambulatory care lapses 
in our study only indicated for diabetes-related visit, and we only consider the 
expenditure for the first ischemic stroke hospitalization after lapses. Beside, a recent 
Taiwanese study examined the trends of healthcare use and costs for patients with type 2 
diabetes mellitus. The results pointed out that diabetic patients with fewer than 3 
diabetes-related physician visits in a year, which considered as irregular diabetes care, 
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tended to consume more inpatient services.79 The result is similar with our study showed 
that longer ambulatory care lapses may incurred the expenditure of hospitalization. The 
difference from previous study and this study is that our study only considered the 
expenditure of ischemic stroke hospitalization, and not included cost from other diseases. 
Therefore, the statistically significant increased expenditure was observed in diabetic 
patients with the last ambulatory care over 365 days.  
The result of this study is consistent with previous studies that average 
hospitalization cost increased with the age increased.66 It is also the same as previous 
studies that diabetic patients with comorbidities in hypertension113,114, atrial fibrillation56,97, 
ischemic heart disease114,115, chronic kidney disease114, and heart failure115 were statistical 
significantly increase average hospitalization cost. However, diabetic patients with stroke 
history showed a negative effect on average hospitalization cost. The result was different 
with previous small study, which showed no association between stroke history and 
hospitalization cost.66 Besides, this study showed that diabetic patients participated DSCP 
were associated with lower average hospitalization cost per day which is the same as 
previous study.116  
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Length of stay of different diabetic ambulatory lapse groups  
The overall median length of stay for the index ischemic stroke (8 days, IQR 5-16 
days) was consistent with previous studies. The result was similar with a small study with 
295 subjects, which indicated acute length of stay for stroke patients was 8 days in 
median.67 The result was also close to a Taiwanese hospital-based study which reported 
median length of stay for ischemic stroke patients was 7 days 69. Besides, a recent 
Taiwanese study investigated cost and length of stay in first-ever and recurrent stroke 
patients. The results found that the average length of stay was 13.9 days, and the most 
common length of stay for ischemic stroke was 5-10 days.66 Although the median length 
of stay between 5 groups did not showed big different (8 to 9 days), the longer lapses 
seemed to have a longer length of stay. 
After controlling for age, sex, comorbidities in hypertension, atrial fibrillation, 
ischemic heart disease, chronic kidney disease, heart failure, participated in DSCP, 
number of diabetic care exams, number of diabetes-related emergency room, number of 
diabetes-related hospitalization visit, and type of medical institution for the index stroke, 
we found that diabetic patient with longer diabetic ambulatory lapses were associated 
with increased length of stay for subsequence ischemic stroke. The results of multivariate 
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regression showed that diabetic patients with the last ambulatory care within 91 to 180 
days, diabetic patients with the last ambulatory care within 271 to 365 days and diabetic 
patients with the last ambulatory care over 365 days seemed to prolong the length of stay 
for the index stroke when compared to diabetic patients with the last ambulatory care 
within 90 days.  
A previous study assessed whether a lapse in Medicaid coverage is associated with 
an increase in expenditures and acute care utilization among beneficiaries with diabetes. 
The results of the study found that individuals with diabetes having a lapse in Medicaid 
coverage was associated with longer inpatient stays. It also found that the length of the 
coverage lapse was not significant associated with the length of inpatient stay.112 Our study 
showed similar results. As compared to patients with the last ambulatory care within 90 
days in this study, the longer ambulatory care lapses showed statistically significant 
increased length of stay, especially for diabetic patients with the last ambulatory care 
within 91 to 180 days, diabetic patients with the last ambulatory care within 271 to 365 
days and diabetic patients with the last ambulatory care over 365 days. However, the 




Besides, this study is consistent with previous studies32,66 showed that patients with 
older age were associated with the longer length of stay for the index stroke. This study 
showed the same result as a previous study117 that male patients have shorter length of 
stay when compared to female patient. Comorbidity in hypertension showed a negative 
effect on the length of stay for the index stroke which is the consistent with a Korean 
study.118 It is known that heart disease is an important factor to increase length of stay for 
stroke. This study is consistent with previous studies showed that atrial fibrillation66,119 and 
heart failure119 had been approved to have a positive effect on stroke length of stay. 
Although ischemic heart disease in this study showed a negative effect, it did not have 
statistically significant. The results showed that diabetic patient with more diabetic-related 
emergency room visit and hospitalization visit were associated with an increased length of 
stay. This is intuitive as one would expect patients with more emergency room visit and 




Stroke severity of different diabetic ambulatory lapse groups 
Although previous results showed only little difference in average hospital cost 
per day and length of stay among different lapses of ambulatory care groups, the odds 
ratio of stroke severity showed a statistically significant increase in patients with longer 
lapses, especially for those patients with the last ambulatory care over 365 days. The 
results from Table 4 showed that diabetic patients with the last ambulatory care within 90 
days had the highest percentage of patients in severity 1 and the lowest percentage of 
patients in severity 2 and severity 3 when compared to the other groups. Besides, diabetic 
patients with the last ambulatory care within 90 days had a lower percentage of 
in-hospital death and discharge under critical condition.  
With controlling for age, sex, comorbidities in hypertension, atrial fibrillation, 
ischemic heart disease, chronic kidney disease, heart failure, participated in DSCP, 
number of diabetic care exams, number of diabetes-related emergency room, number of 
diabetes-related hospitalization visit, and type of medical institution for the index stroke, 
the multinomial logistic regression model found that diabetic patients with the last 
ambulatory care within 91 to 180 days, diabetic patients with the last ambulatory care 
within 271 to 365 days and patients with the last ambulatory care over 365 days reported a 
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severer ischemic stroke when compared to diabetic patients with the last ambulatory care 
within 90 days.  
It is known that frequent visits to diabetes care clinics linked with better control of 
diabetes mellitus. The United State studies indicated that diabetic patients who had a 
clinic visit of 1 to 2 weeks achieved better and faster control in HbA1C, blood pressure, 
and low-density lipoprotein cholesterol compared to those had a clinic visit every 3 to 6 
months.76,77 A previous study evaluated the relationship between missed appointments 
and glycemic control. The results found that patients who missed more than 30% of their 
appointments were less likely to practice daily self-monitoring of blood glucose and to 
have poor oral medication refill adherence.120  
On the contrary, diabetic patients with longer ambulatory care lapses may imply 
that they do not have diabetes care for a longer time. A previous study identified young 
adults with type 1 diabetes who had been lost to follow-up during their transfer from 
pediatric to adult care and compared the clinic outcomes to participants receiving 
continuous care. The results showed that lapse care participants as compared with 
continuous care participants had a higher HbA1C and reported a greater proportion of 
severe hypoglycemia.121 Long-term hyperglycemic can cause endothelial dysfunction, 
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and organs within bodies will also be damaged. When diabetic patients suffer from an 
ischemic stroke, the severity may increase within these groups of patients. A newly study 
assessed whether HbA1c-based adjusted glycemic variables were associated with 
unfavorable outcomes of stroke hospitalization. The result found that glycemic gap in 
diabetic patients were associated with acute ischemic stroke severity.122 Besides, frequent 
ambulatory care visit for chronic diseases is to prevent its complications. A recent study 
assessed the impact on foot complications of time between the onset of symptoms of 
diabetes and the physician visit, and indicated that waiting for >1 month after symptoms 
onset dramatically increases the risk of diabetic foot complications.123 Moreover, a 
previous study examined whether ambulatory visits are associated with decreased stroke 
and death in hypertensive patients , and found that ambulatory visits prior to event were 
associated with decreased death.124  
Age is a predictors factors of index stroke severity which is consistent with intuitive 
as older patients to be more impaired from stroke. The result of this study is the same as a 
previous study that male patients seemed to have a less severe stroke than female 
patients.125 The result of this study is consistent with previous studies that patients with 
comorbidities in atrial fibrillation126, stroke history, chronic kidney disease127 and heart 
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failure128,129 seem to increase the severity of stroke. The results are also consistent with 
intuition that diabetic patients with more diabetic care was associated with less severe of 
stroke, and more diabetic-related emergency room visits and hospitalizations seem to 




Diabetic Patients with subsequence ischemic stroke having diabetic ambulatory 
lapse over 365 days prior to stroke 
According to the above results, this group of patients were older, having higher 
percentages of highly symptomatic disease, less use of diabetes-related emergency visit 
and hospitalization. Also, they were associated with a lower participation rate in DSCP and 
a lower percentage to receive HbA1c test, cholesterol test, dilated eye test, and 
microalbumin test. Moreover, the study results found this group of patients were likely 
associated with higher average stroke hospital expenditure, the increase of stoke length of 
stay, and severer of ischemic stroke. 
The significant results in diabetic patients with subsequence ischemic stroke having 
the last ambulatory care over 365 days prior to stroke could be due to following reasons. 
First, this group of diabetic patients may be lack of access to care which resulted in longer 
lapses. Insurance coverage, such as Medicaid in the U.S., can result in inadequate access to 
care.112 However, there is little influence from insurance coverage since Taiwan conducted 
National Health Insurance program. Also, this group of patients may have difficulties in 
accessing healthcare, including problems getting appointments in primary care, costs of 
transportation and other expenses56,130,131, and problems accessing medications.130-133 
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Besides, this group of diabetic patients may have limited mobility or disability131,134. They 
may need someone accompanied for healthcare, but lack of family support135-137. 
Moreover, diabetic patients with longer lapses may have other factors that preoccupied 
their diabetic ambulatory care. They may have a higher probability to suffer a serious 
household medical event (e.g. heart attack), shift in family structure (e.g. death of a partner) 
since this group of patients were older.100 
Other factors that may influence this group of patients included insufficient 
knowledge on prevention and on support from social and health care systems56,130,131,137, 
differences in perceptions of health that are culturally based, difficulty coping with 
comorbid conditions131, or desire to reduce aging associated functional decline which 






This dissertation sought to understand the relationship between ambulatory care 
lapses and stroke medical utilization in diabetic patients with subsequence ischemic 
stroke. Although this study identified consistent results with previous studies in several 
aspects for diabetic patients with subsequence stroke, there was no study focused on the 
pattern of diabetic ambulatory care lapses. Only few studies investigated on the 
relationship between lapses and medical utilization. One study pointed out that lapses in 
Medicaid coverage were associate with increased expenditure in post-lapse periods.112 
The other Taiwanese study examined the healthcare use and cost in patients with type 2 
diabetes, and found that patients with less than 3 visits per year tended to consume more 
inpatient services.79 
In this analysis of a nationwide cohort study of stroke patients with diagnosed 
diabetes mellitus, we retrieved 76,194 (27.4%) patients aged 20 and older from 2002 to 
2012 for analysis. Patients were divided into five groups based on the different duration 
of diabetic ambulatory care lapses prior to the index stroke. Among overall diabetic 
patients with subsequence ischemic stroke, we found that more than half (59%) of 
diabetic patients had the last diabetic ambulatory care within 90 days prior to stroke, and 
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more than one-fourth (27.8%) of diabetic patients had the last diabetic ambulatory care 
over 365 days prior to stroke. The results were summarized below to answer the study 
aims.  
Aim1: To understand the baseline characteristics for different pattern of ambulatory 
care in diabetic patients 
Among overall diabetic patients with subsequence ischemic stroke, diabetic 
patients with the last ambulatory care over 365 days prior to stroke were older, more male 
when compared to other groups. Diabetic patients, who had subsequence ischemic stroke, 
with longer diabetic ambulatory care lapses prior to stroke tended to have higher 
percentage in highly symptomatic comorbidities, such as atrial fibrillation, ischemic heart 
disease, stroke history, chronic kidney disease, and heart failure, when compared to those 
patients with the last ambulatory care within 90 days prior to stroke. Besides, diabetic 
patients, who had subsequence ischemic stroke, with the last diabetic ambulatory care 
over 365 days prior to stroke was found to have less diabetic-related emergency visit and 
hospitalization prior to stroke when compared to other groups. 
Aim2: To understand the utilization of ambulatory care among diabetic patients 
prior to stroke hospitalization 
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The results showed that diabetic patients with subsequence ischemic stroke 
having shorter diabetic ambulatory care lapses had higher percentage of participating in 
diabetic shared care program and receiving diabetic care exams. The study results found 
that diabetic patients with subsequence ischemic stroke having the last diabetic 
ambulatory care over 365 days prior to stroke had the lowest percentage (0.6%) in 
participating diabetes shared care program, whereas diabetic patients having the last 
diabetic ambulatory care within 90 days prior to stroke were 20.8%. Diabetic patients 
with subsequence ischemic stroke having the last diabetic ambulatory care over 365 days 
prior to stroke had lower percentage of diabetic care exams, including HbA1c test 
(24.5%), cholesterol test (43.4%), eye exam (14.6%), and microalbumin/urine test 
(11.3%).  
Aim3: To understand whether ambulatory care lapses in diabetic patients prior to 
stroke hospitalization is related with stroke medical consumption 
Among diabetic patients with subsequence ischemic stroke, this study found 
following relationship between diabetic ambulatory care lapses and stroke medical 
consumption. The results found that diabetic patients with the last ambulatory care over 
365 days prior to stroke was significantly associated with higher average stroke hospital 
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expenditure. Compared to diabetic patients with the last ambulatory care within 90 days 
prior to stroke, the average stroke hospital cost per days was 1.06 times higher in those 
with the last ambulatory care over 365 days prior to stroke.  
Besides, the results of this study indicated that diabetic patients with the last 
ambulatory care over 90 days prior to stroke was likely associated with the increase of 
length of stay in subsequence stroke hospitalization. Compared to diabetic patients with 
the last ambulatory care within 90 days prior to stroke, the length of stay was 0.79, 1.04, 
and 0.61 days longer in those with the last ambulatory care within 91~180 days prior to 
stroke, the last ambulatory care within 271~365 days prior to stroke, and the last 
ambulatory care over 365 days prior to stroke. However, increased length of stay did not 
present a trend relationship with ambulatory care lapses increased.  
Moreover, the results showed that diabetic patients with the last ambulatory care 
over 90 days was associated with increased severity of ischemic stroke. Compared to 
diabetic patients with the last ambulatory care within 90 days, the odds ratio of stroke 
severity 2 to stroke severity 1 was 1.12, 1.13, 1.14 in those with the last ambulatory care 
within 91~180 days, the last ambulatory care within 271~365 days, and the last 
ambulatory care over 365 days; the odds ratio of stroke severity 3 to stroke severity 1 was 
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1.24, 1.20, 1.34 in those with the last ambulatory care within 91~180 days, the last 
ambulatory care within 271~365 days, and the last ambulatory care over 365 days.  
In summary, the results found that diabetic patients with subsequence ischemic 
stroke having the last diabetic ambulatory care over 365 days prior to stroke were 
associated with increased hospitalized expenditure, length of stay, and severity for stroke 
although we had controlled possible confounding factors. Although this study using 
Taiwanese data as an example, our findings could be consistent with other countries. 
Therefore, the recommendations from this study may be more closely applicable to 
countries with healthcare insurance system, public health systems, electronic health 





Based on the above results, diabetic patients with the last ambulatory care over 
365 days prior to stroke had higher stroke expenditures, longer length of stay and severer 
stroke. So, diabetic ambulatory care lapses could be an important indicator for diabetic 
patients care management. It is needed to be great concerned for diabetic patients with 
the last ambulatory care over 365 days prior to stroke. Therefore, this study provided 
several suggestions in management and clinical aspects.  
For health care administrators, this study suggests that they should initiative to 
understand how frequently miss appointments occurred for diabetic patients and to follow 
diabetic patients with ambulatory care lapses over 365 days. We also suggest that health 
care facilitates establish a community health worker system in order to get close with 
diabetic patients. The community health worker system includes a nurse case manager 
and several community health workers, with providing basic diabetes information and 
content of diabetes-related behaviors for diabetic patients, especially for those with 
longer ambulatory care lapses. According a previous study138 which adapted community 
health worker diabetes intervention, it significantly increased primary care physician 
visits, and decreased emergency department visits among those with high emergency 
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department utilization. The community health worker system suggests important and 
beneficial impacts on health system utilization from the diabetes intervention in a low 
resource and high-risk population. Besides, the community health worker system expects 
to enhance continuous of diabetes care and to reduce medical expenditure for the 
subsequence ischemic stroke. 
For government policy, this study suggests that an indicator of ambulatory care 
return rate should be added in recent program, and additional reward for health care 
facilitates should be provided by National Health Insurance Administration if a lower 
percentage of miss appointment for ambulatory care within 365 days in diabetic patients. 
The Diabetes Shared Care Program had provided financial incentive in several ways, 
such as body mass index, diet and exercise, smoking, blood pressure, weight management 
counseling, medication reconciliation, HbA1c testing and annual lipid profile. Besides, 
several previous studies had indicated that pay-for-performance program for diabetes was 
associated with a significant increase in regular follow-up visits and evidence-based 
services, and significantly lower hospitalization costs.116,139 Since ambulatory care lapses 
could be an important indicator in diabetes care management, the financial incentive 
expects to motive health care facilitates on ambulatory care monitoring for diabetic 
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patients, especially for those with ambulatory care lapses over 365 days. It will also offer 
financial relief for further diabetes complications and hospital visits in long term.  
For medical professionals, this study suggests that medical professionals should 
make the best of a cloud-based medication system to understand diabetic care exams for 
diabetic patients. It is known that a cloud-based medication records system is a 
convenient platform for sharing data among healthcare providers in different 
institutions,140 and many countries are devoted to develop, such as Austria and India. 
Taiwan National Health Insurance Administration launched PharmaCloud system in 2013 
to integrate patients’ medication lists, exams, and operations among different medical 
institutions. The system enables physicians at contracted medical services providers to 
search patients’ medication records over the previous three months.141 A previous study 
indicated a moderate satisfaction toward the PharmaCloud system. However, physicians 
and community pharmacists had a lower satisfaction rate than hospital pharmacists.142 
Therefore, it is important to encourage medical professionals to use PharmaCloud system 
and to provide appropriate diabetic care exams for diabetic patients, especially for those 
patients with longer lapses.  
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Finally, this study suggests that further researches can focus on diabetic patients 
with ambulatory care lapses over 365 days prior to stroke in order to understand the 
discontinuity of ambulatory care. Because of the characteristic of the database, we cannot 
get a deeper understanding of this group. It is suggested to use a database linking claim 
data with detailed community-based survey data, such as Community Health Needs 
Assessment in the U.S., for further researches. Based on the study results, more than 
one-fourth of diabetic patients with the last ambulatory care over 365 days prior to stroke. 
This group of patients were associated with an increased stroke medical expenditure, 
length of stay, and severity. Therefore, it is better to investigate the reason of longer 
ambulatory care lapses behind this group of patients. Besides, further researches could 
consider how to divide the population since there were few patients in the middle of three 
groups. This study used a strict three-months period for grouping, but some patients may 
not have a follow-up visit within three months. Moreover, it could be further investigated 
whether patients with type 1 diabetes or type 2 diabetes have different behavior of 




Limitations and Strengths 
There are several strengths for this study. First, this is the first study to 
demonstrate the relationship between duration of diabetic ambulatory lapses and 
subsequence ischemic stroke from a nationwide database. Patients with chronic disease is 
highly recommended to manage their disease with regular appointments in ambulatory 
care setting. However, few studies focus on ambulatory lapses, especially on specific 
diseases. Second, Taiwanese National Health Insurance Research Database is a national 
database with standard formats for all reimbursement records. The longitudinal database 
with large sample size provided a good opportunity to study diabetic patients’ behavior, 
especially for ambulatory care and their subsequence stroke utilization. The Taiwanese 
National Health Insurance Database has been used a lot in researching the relationship 
between diabetes and risk of stroke in the past years. However, the diabetic ambulatory 
care behavior is lacking. Finally, this study is a retrospective cohort study design. The 
design provided us to study multiple outcomes of stroke, such as expenditure, length of 
stay, and severity. Also, it is less time consuming and costly then prospective design. With 
the understanding of duration of diabetic ambulatory care lapses before stroke 
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hospitalization among diabetic patients with subsequence stroke, this study will increase 
the awareness in diabetic ambulatory care.  
On the other hands, this study has some limitations. First, this is a retrospective 
cohort study design by using claim data, both the exposure and outcome have already 
occurred at the outset of the study. We must rely on others for accurate recordkeeping. Also, 
information on several confounding variables may be unavailable, inadequate or difficult 
to collect. Therefore, we cannot explain why patients miss follow-up appointments and 
why physicians provide some kinds of medical care. Therefore, a prospective research is 
recommended to conduct. Second, comorbidities that have no immediate effects, such as 
hyperlipidemia, may be underestimated. This is because that comorbidities are defined by 
numbers of physician visits, and patients may ignore comorbidities with less highly 
symptomatic. Therefore, the adjusted models did not include comorbidity in 
hyperlipidemia, but we adjust all obtainable demographic and other comorbidities. Third, 
the index stroke may be not the first stroke for study population. We had excluded patients 
with late effects of cerebrovascular disease in any place of diagnoses. Also, we excluded patients 
with any stroke hospitalization in calendar year 1997 to 2001. Therefore, the index stroke 
may be not the first stroke was more possibly in the early calendar year. Finally, the claim 
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database does not contain data on clinical stroke scales for severity, as well as ischemic 
stroke types. Therefore, this study adopted a validated proxy for stroke severity, the stroke 
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Table 1 Order code for diabetic care exams in claim data 
Items Order codes 
HbA1c test 09006 
Cholesterol test 1) 09001 and 09004 and 09043 
2) 09001 and 09004 and 09044 
3) 21 and IC21, 22 and IC22, 25 and IC23, 27 and IC24, 21 and 
L1001C and IC21, 25 and L1001C and IC23 
Eye exam 23501, 23502, 23702 
Urine microalbumin 
test 





Table 2 Order code for Stroke Severity Index in claim data 
Items Order codes 
Airway suctioning 47041C, 47042C 
Bacterial sensitivity 
test 
13009B, 13009BB, 13010B, 13010BA, 13011B, 13011BB, 
13020B 
General ward stay 03002A, 02006K, 02007A, 02008B, 03001K, 03003B, 03004B, 
03005K, 03006A, 03007B, 03008B, 03026K, 03027A, 03028B, 
03029B 03002AB      
Intensive care unit 
stay 
02012A, 02011K, 02013B, 03010E, 03010K, 03011A, 03011F, 




47017C, 47018C, 47018CA 
Osmotherapy A009633266, A009633255, A009633277, A009745277, 
A013354277, A015561255, A015561266, A015561277, 
A016476238, A016476266, A016476277, A031387238, 
A033425266, A042601238, B014379277, B020322265, 
B020322277, N012343266, A023733263, A023733265, 
A023733266, A023733277, A024986209, A024986265, 
A024986266, A024986277, A025104266, A025104277, 
A025355266, A025355277, A026793265, A026793266, 
A026793277, A028475265, A028475277, A029475265, 
A029475277, A034722277, AC23733263, AC23733266, 
AC23733277, AC24986265, AC24986266, AC24986277, 
AC28475277, AC29475265, B006604277, B017082263, 
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